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Abstract 
Centers for Disease Control (2011a) Surveillance report revealed African 
American women comprised 63% of new HIV cases among women; 65% of African 
American women were infected with HIV transmitted by heterosexual sex; yet represent 
13% of the female population in the United States. An existing data set was examined 
from a sample of 761 African American women with a history of drug use at high risk to 
acquire or transmit HIV and/or STDs to determine 751 women’s knowledge and attitudes 
about risky sexual behaviors, factors influencing a decision to HIV test, and the influence 
of sex trading on the decision to HIV test.  
Binary logistic regression predicted a small percentage of women’s decision to 
HIV test was influenced by knowledge of risky sexual behaviors (Naegelkerke R
2
, = 
.100). There were significant difference in the number HIV tests for women who reported 
cheating on a steady sex partner (M = 4.25, SD =7.49) versus women who did not cheat 
(M = 3.28, SD = 4.67), t(747) = - 2.19, p = .03.  Binary logistic regression predicted a 
minor percentage of women’s decision to HIV test was influenced by women’s attitudes 
about risky sexual behavior (Nagelkerke R
2
 = .043). Women who agreed with the 
statement, I have risk drug behaviors that need changing were predicted to be twice as 
likely to HIV teste Exp [B] = 1.829, 95% CI [1.018, 3.288]. Binary logistic regression 
predicted an increased 15.3% variation in the decision to HIV test is influenced by 
women’s knowledge to prevent HIV and attitudes about risky sexual behavior 
(Nagelkerke R
2
 = .153).  Women who agreed with the knowledge item, asked their 
partner if they were HIV positive, were 1.3 times more likely,  and women who agree 
with the knowledge statement, I have risky drug behaviors that need changing, increased 
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to 1.9 times more likely to HIV test. There were significant differences in number of HIV 
tests for women who engaged in sex-trading versus women who do not engage in sex-
trading. Tailored strategies that determine unique needs of African American women to 
reduce risky sex an increase HIV testing are recommended.  
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Chapter I 
Background 
The human immunodeficiency virus (HIV) infection is responsible for causing 
Acquired Immune Deficiency Syndrome (AIDS).  According to the Centers for Disease 
Control and Prevention (CDC) Human Surveillance Report 2011 published in 2013, “At 
the end of 2010, an estimated 872,990 persons in the United States (U.S.) were living 
with diagnosed HIV infection and an estimated 487,692 persons in the U.S. were living 
with infection classified as stage 3 AIDS” (CDC, 2013a, p.9, 10).  In 2011, there were 
50,007 new cases of HIV diagnosed in the U.S., adult and adolescent women accounted 
for 10,512 (21%) of the reported cases and adult and adolescent women prevalence rate 
was 165.2 per 100,000 population (CDC, 2013a).  
The CDC HIV Surveillance Report 2011 published in 2013 revealed that 
heterosexual contact has accounted for 9,026 (85.9%) of all women diagnosed with HIV.  
Intravenous drug use (IDU) is the second mode of transmission of HIV among all women 
who are currently HIV positive and newly diagnosed with HIV; IDU accounted for 1,471 
(14%) of all women diagnosed with HIV in 2011 (CDC, 2013a).  
Initially, HIV was thought to be an infection affecting only gay men who 
participated in homosexual behavior or individuals who used intravenous drugs (CDC, 
1981). Women were not thought to be a population at risk for HIV, and heterosexual 
behavior was not considered a high risk behavior or a mode for the transmission of HIV 
(CDC, 1981, 1982). The CDC (1982) did allude at this point in time that there may be 
unknown risk factors present for HIV; because, there were a small percentage of reported 
HIV cases that presented with none of the known HIV risk factors.  Between April 1981 
and April 1982, five women previously considered healthy presented at New York City 
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hospitals with Pneumocystis carinii pneumonia and decreased cellular immune function 
resulting in hospital admissions (Masur et al., 1982). Masur et al. questioned each of the 
women about their sexual history. Four of the five women were heterosexual and one was 
bisexual with a concurrent relationship with a man and woman during the12 months prior 
to hospitalization (Masur et al.).  History of drug use among the five women showed (a) 
three of the women had IDU of cocaine and heroin, (b) one woman admitted to using 
non-intravenous drugs, (c) the fifth woman denied drug use, but disclosed her sexual 
partner used intravenous heroin, and (d) all five of the women denied participation in sex-
trade or being promiscuous (Masur et al.). In 1982, Masur et al. reported the first women 
with HIV. 
 In 1983, transmission of HIV to women from HIV infected male partners was 
recognized as an identifiable HIV risk factor (CDC, 1983a). The initial HIV/AIDS 
research and clinical trials focused on the male population. In 1986, women and 
minorities were recognized as the most rapidly emerging population with HIV in the U.S. 
(CDC, 1986). In 1986, the National Institute of Health (NIH) amended research 
guidelines to include women in HIV/AIDS clinical trials; in 1987 the guidelines are 
amended to include minorities.  Likewise in 1990 the CDC identified an increased 
incidence of HIV/AIDS among women, yet research studies failed to include women. In 
1990 the National Institutes of Health (NIH) provided testimony recognizing the poor 
adherence to including women and minorities in HIV clinical trials because of 
inconsistent guidelines, awareness, and adoption (Kass, Taylor, & King, 1996).  Women 
were included in the 1991 HIV/AIDS epidemiology studies as a result of the 1990 NIH 
mandates for inclusion of women in HIV/AIDS research.   
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In 1990, the NIH (1990) acknowledged “the underrepresentation of women in 
such studies resulted in significant gaps in knowledge” (p.2).  According to Kass et al. 
(1996), the concern of teratogen effect was a key reason women were not included in 
HIV/AIDS clinical trials; the researchers feared clinical trial drugs could trigger 
abnormal prenatal development or interfere with a woman’s fertility. In 1994, the NIH 
provided supplemental guidelines to the NIH Revitalized Act of 1993 directing research 
to include women, minorities, and sup-populations.  
Researchers were slow to address the health care of women with HIV (CDC 
1986; NIH 1990, 1994).  This resulted in the NIH increasing directives to include women 
in HIV clinical trials (NIH 1986, 1990, 1994).  The U.S. Department of Health and 
Human Services (HHS) was also slow to disseminate public information regarding 
women and HIV.  A Guide to the Clinical Care of Women with HIV, was the first gender 
specific manual addressing the needs and care of women with HIV (Anderson, 2001). 
Significance of the Problem 
According to the CDC (2013b), in 2011, there were 136,690 African American 
women living with HIV infection and 5,311 African American women with initial test 
results classified as AIDS.  African American women accounted for 6,623 (63%) of new 
female HIV cases reported in 2011 (CDC, 2013a).  In 2010, AIDS was ranked among the 
top 10 causes of mortality for African American women aged 25 to 64 years (CDC, 
2013c).  
There is a disproportion of HIV and AIDS among African American women. 
African American women represent 64% of the HIV/AIDS cases among women (CDC, 
2008); yet African American women represent 13% of the female population in the 
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United States (U.S.) (U.S. Census Bureau, 2003). In 2011, the CDC also reported that 
again the majority of women diagnosed with HIV were African American women 5,882 
(65.2%), 1,522 (16.9%) were Caucasian women, and 1,522 (16.9%) were 
Hispanic/Latina women (CDC, 2011a). Additionally, African American women are 
disproportionally being diagnosed with HIV in comparison to other races/ethnicities. 
African American women are diagnosed with HIV at a rate 20 times higher than 
Caucasian women and five times higher than Latina woman (CDC, 2014a). According to 
CDC (2013b) published report, it is estimated that 1 in 32 African American women will 
be diagnosed with HIV during their lifetime compared to 1 in 106 Hispanic/Latina 
women, and 1 in 526 Caucasian women (2013b). The CDC reported that in 2011 there 
were 10,512 cases of HIV among women by race/ethnic background: (a) 63% 
Black/African American, (b) 17% Hispanic/Latina, (c) 17% Caucasian, (d) 1% Asian, 
(e)1% multiple races, (f) < 1% American Indian/Alaska Native, and (g) < 1% Native 
Hawaiian/ Pacific Islander (CDC, 2013a).  
Statement of the Problem 
Women are more susceptible to be infected with HIV due to: (a) larger surface 
area of the genital tract for exposure to the virus, (b) the length of time infectious fluids 
are in the genital track during intercourse, and (c) a dark moist genital tract provides an 
optimum environment for viral and bacterial growth (Higgins, Hoffman, & Dworkin, 
2010; HHS Office of Women’s Health, 2009; Moench, Chipato, & Padian, 2001). The 
biological reason women are susceptible to HIV is related to cervical function, which 
protects the uterus from infection. The cervix houses an abundance of CD4 cells to fight 
infection, and peristalsis promotes the sperm advancing forward to the uterus (Galan, 
 Green, Lisa, UMSL 14 
 
2010; Higgins et al.; 2010; Moench et al., 2001). This is an important factor because the 
lifecycle of HIV proliferates by binding with a CD4 cell and targets the CD4 cells of the 
cervix (Green, 2007; Moench et al., 2001). The viral load in the semen has been found to 
be much higher initially than the serum blood viral load, which increases the HIV risk for 
women (HHS Office of Women’s Health, 2009). Additionally if women have an 
inflamed vagina and/or cervix, there is breakdown of the mucous membrane that can 
increase women’s susceptibility to HIV (Higgins et al., 2010; Moench, et al. 2001; HHS 
Office of Women’s Health, 2009). It follows that women with risky sexual behaviors 
have a greater chance of contracting HIV and STDs (HHS Office of Women’s Health, 
2009).  
The CDC (2010a) reported that a person infected with an STD is two to five times 
more likely to contract HIV than a person who does not have an STD.  CDC (1998) 
reported that biological plausibility of an established STD can promote the body’s 
susceptibility to HIV and transmission of HIV. In addition, the presence of a venereal 
genital ulcer caused by STDs such as genital herpes, syphilis, genital warts and others 
creates a physical vulnerability providing a port of entry for the HIV as result of the 
breakdown in the skin and mucous membrane; because, this ulcerative or non-ulcerative 
STD triggers an inflammatory process that increases the presence of CD4 count that 
attracts the HIV infection (CDC, 2010a; Spinola et al., 1996).   
The human immunodeficiency virus (HIV) can be a manageable chronic illness if 
detected. HIV management with the most current antiretroviral drug regime can diminish 
the viral load to almost non-detectable levels, which reduces the risk of transmission 
(HHS, 2011; Donnell et al., 2010). If HIV is detected before the immune system is 
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compromised, effective management can thwart opportunistic infections (HHS, 2011). 
Additionally if HIV is detected, the management of the disease can impede the 
progression to acquired immune deficiency syndrome (AIDS) and death (HHS, 2011). 
Early identification and management of HIV can improve patient outcomes (CDC, 2006).  
Thus, it is important that individuals with high risk behaviors be tested for HIV. 
At the end of 2010, an estimated 223,045 adolescent and adult women were living 
with HIV; African American adolescent and adult women accounted for 60% (133,827) 
living with HIV (CDC, 2013a). Historically, in 2004, AIDS was the primary cause of 
death for African American women between the ages of 25 to 34 years, ranked third as 
cause of mortality for African American women ages 35 to 44 years, and a ranked fourth 
as cause of mortality for African American women ages 45-54 years (CDC, 2008).  
However, the latest estimates in 2010 revealed more women living with HIV, but a 
decrease in deaths related to AIDS (CDC, 2013a, 2010b).  In 2010 AIDS was the fifth 
leading cause of death for African American women between the ages of 25 to 34 years, 
ranked fourth as cause of mortality for African American women ages 35 to 44 years, and 
ranked sixth as cause of mortality for African American women ages 45-54 years. 
Although deaths related to AIDS have decreased, African Americans accounted for 49% 
of the deaths in 2011 with mortality rate of 25 per 100,000 (CDC, 2013a). 
High risk heterosexual behavior accounted for 74% of the HIV/AIDS cases 
among African American women (CDC, 2008). Routine HIV testing may provide for 
earlier recognition of the virus, and referral for disease management that may prevent the 
acceleration of the HIV disease to AIDS.  With the rising numbers of African American 
women testing positive for HIV, additional research is needed to determine factors that 
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will influence African American women to seek HIV testing. Therefore, it is important to 
study if African American women’s knowledge of risk behaviors can influence early HIV 
testing.  
Purpose of the Study 
The purposes of this investigation are to determine if knowledge and attitudes 
about risky sexual behaviors and HIV/AIDS influence the decision to participate in HIV 
testing, and if sex trading influences the decision to participate in HIV testing among 
women with a history of drug use. 
This study is designed to answer the following research questions: 
1. What knowledge do women have about actions before and after sex to prevent 
acquiring HIV or STDs? 
2. What are women’s attitudes about risky sexual behaviors? 
3. Will women’s knowledge about risky sexual behavior influence her decision to 
have HIV testing? 
4. Will women’s attitudes about risky sexual behavior influence her decision to have              
HIV testing? 
5. Are there interactions between women’s knowledge to prevent HIV, attitudes 
about risky sexual behavior, and the women’s decision to have HIV testing? 
6. Is there difference in women who engage in sex-trading versus women who do 
not engage in sex-trading and their decision to have HIV testing? 
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Definition of Terms 
Human Immunodeficiency Virus (HIV). The HIV is a retrovirus belonging to 
the “Lentivirus subfamily” (Green, 2007). This retrovirus is replicated through the 
transcription of the ribonucleic acid’s (RNA) genetic viral code into the deoxyribonucleic 
acid (DNA) of the host cell by the enzyme, reverse transcriptase (Green, 2007). The HIV 
merges into the CD4 cell provoking a dysfunctional immune system (Green, 2007).  
Acquired Immune Deficiency Syndrome (AIDS).  Acquired Immune 
Deficiency Syndrome (AIDS) is the continuous replication of the HIV virus, the 
reduction of the CD4 count, and the gross deterioration of the immune system.  As the 
viral load increases, the CD4 count continues to diminish < 200/mm
3 
(Department of 
Health and Human Services, 2011; Maceda Lan, 2003).  
CD4. The CD4 is frequently identified as a T helper cell. The T lymphocyte is a 
type of white blood cell produced from the thymus that is part of immune system (Mosby 
Dictionary, 2008). The CD 4 cell is a protein attribute on the surface of the helper T4 
lymphocyte, which alerts the immune system to activate the body’s immune response to 
bacterial or viral invasion (Mosby Dictionary, 2008).  
Viral load. Viral load is the measurement of the circulating of HIV RNA counted 
in the plasma. Viral load is determined by using one of the following tests:  (a) the 
branched DNA (bDNA) assay, (b) polymerase chain reaction (PCR), and (c) the nucleic 
acid sequence based amplification ([NASBA]; Green, 2007).  
 Early HIV detection: Early HIV detection is the ability to detect the presence of 
HIV RNA and p24 antigen found in serum and plasma (usually up to six months after 
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infection) before detectable HIV antibodies can be measured (Department of Health and 
Human Services [HHS], 2013).  
Sexually Transmitted Disease (STD).  An STD is an infectious pathogen 
transmitted through sexual activity (CDC, 2010c). The HIV is also considered to be an 
STD since one of the modes of transmission is through sexual activity (CDC, 2010c).  
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Chapter II 
Review of the Literature 
This chapter presents a review of the literature and the conceptual model based on 
this review. The review of the literature is discussed and summarized as it relates to 
factors that influence HIV testing among African American women and their risk for 
HIV. 
Conceptual Model 
The conceptual model is based on the review of the literature and is designed to 
identify factors that influence HIV testing among African American women with a 
history of drug use (see Figure 1).  The model includes the following concepts: African 
American women with a history of drug use, drug use behaviors, trading sex behaviors, 
risky sexual behaviors, attitudes about HIV/AIDs and risky sexual behaviors, knowledge 
about actions to prevent getting HIV or STDs, and HIV testing.  
Conceptual Definitions 
 The conceptual definitions related to the conceptual model intended to guide this 
study include:  
African American Women with a History of Drug Use 
 African American women with a history of drug use is defined as a positive urine 
drug test for cocaine, amphetamines, or opiates; and/or physical presence of track marks 
from recent intravenous drug use (Cottler, 2006).   
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Risky Sexual Behaviors 
 
 
Trading Sex Behaviors 
 
 
Drug Use Behaviors 
 
Drug Use Behaviors 
Drug use behaviors are defined as persons who use commonly abused drugs: 
alcohol, marijuana or hashish, K2Spice (synthetic marijuana) heroin, heroin or cocaine 
mixed together (speedball), bath salts, amphetamines, ecstasy/Molly (GHB or other club 
drugs), hallucinogens, inhalants, or other drugs such as prescription drugs (CDC, 2011b).   
Figure 1. African American Women with Drug Use and HIV Testing 
 
 
 
 
        
 
 
 
 
 
 
   
 
 
Risky Sexual Behaviors 
 Risky sexual behaviors are defined as engaging in the act of sex without 
considering the known risks of sexual activity, engaging in sex without considering 
personal or partner’s risks, and misperception or lack of knowledge of the risk behaviors 
African American Women 
with a History of Drug Use 
Attitudes about HIV/AIDS 
and   
Risky Sexual Behavior 
 
Knowledge about 
Actions to Prevent HIV 
or STDs 
 
 
HIV Testing 
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that constitute risky sexual behavior (CDC, 2008). Risky sexual behavior is characterized 
by unprotected sex, trading sex, STD, having multiple sex partners, unaware of sex 
partner’s risk factors, or intravenous drug using sex partner (CDC, 2008).   
Trading Sex Behaviors 
 Trading sex behaviors are defined as illegal transactions based on a verbal 
agreement to provide a sexual service for a commission of money, drugs, acquisition of 
temporary residence or necessities of food and clothing (Cottler, 2006).  
Attitudes about HIV/AIDS and Risky Sexual Behavior  
Attitudes about HIV/AIDS and risky sexual behavior is defined as a person’s 
personal belief or perspective about HIV/AIDs  risk present when engaging in sex and 
may be influenced by cultural background resulting in engaging in risky sex even though 
risk is known (Duvall et al., 2013).   
Knowledge about Actions to Prevent HIV or STDs 
 Knowledge about actions to prevent HIV or STDs is defined as the persons 
understanding of behaviors to take before and after sex to keep from getting HIV or 
STDs (Cottler, 2006).  
HIV Testing 
HIV testing is defined as person having an HIV test that detects presence of 
circulating HIV antibodies (CDC, 2014b). 
African American Women with a History of Drug Use  
Women who are drug addicted are more likely to act, not contemplate behavior 
risks or the consequences to their health (National Institute of Drug Abuse [NIDA], 
2012).  In general, drug use alters thinking processes, promotes impulsivity, and distorts 
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judgment (NIDA, 2012). Among women who are drug addicted, African American 
women compared to Latina and Caucasian women  are more likely to have unprotected 
sex, more than one sex partner, and sex with high risk partners, or trade sex for money or 
drugs (Jenness et al., 2010).  Drug use can lead to a plethora of health issues but the 
major health issue for this population with a drug use history is that drug use predisposes 
the body to infection such as HIV or Hepatitis C (NIDA, 2012).  This risk for infection, 
coupled with having sex with high risk partners, places these women at high risk for HIV 
and STDs (NIDA).  
According to the CDC (2013a), HIV transmission by intravenous drug use among 
women accounted for 14% of the overall female HIV cases; African American women 
accounted for almost half (48.7%) of the HIV cases by IDU. The CDC recognized early 
on that the use of intravenous drugs places individuals at risk for HIV (CDC, 1982).  In 
general, women who use injectable drugs and other substances are at risk for HIV due to 
either sharing needles or engaging in high risk behaviors for HIV (CDC, 2014a).  In an 
earlier descriptive case-control study of HIV positive African Americans in North 
Carolina, of the 276 women in the sample (128 HIV positive and 148 HIV negative), the 
researchers found over a three month period that 38 (30%) of the HIV positive women 
reported illicit drug use with their three most recent sex partners and 61 (48%) reported 
partners using illicit drugs (Doherty, Schoenbach, & Adimora, 2009). In contrast, 7 (5%) 
of HIV negative women reported illicit drug use with their three most recent partners and 
25 (17%) reported partners using illicit drugs (Doherty et al.).  
Schӧnnesson et al. (2008) used a cross sectional design to study 258 HIV positive 
African Americans (120 [47%] men, 138 [53%] women, median age 44) who engaged in 
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crack cocaine smoking in the past 30 days, self-identified as heterosexual, smoked crack 
cocaine in the previous 48 hours, had vaginal sex in the past 30 days, and showed proof 
of positive HIV test or HIV prescription medications. The researchers explored HIV risk 
behaviors among crack cocaine smokers by creating three clusters of risk behaviors: 
highest risk, consistent condom use meaning a condom is used always, and inconsistent 
condom use meaning condom is used less than always (Schӧnnesson et al.).  The cluster 
with the highest risk (52 [58%] men, 59 [53%] women) were participants, who self -
reported: (a) more than one time a day crack cocaine smoking, (b) more than two 
partners, (c) traded sex for money or drugs, and (d) inconsistent condom use. The cluster 
of participants who had used condoms consistently included 29 (53%) men and 25 (47%) 
women; and the cluster of inconsistent condom users’ had 39 (42%) men and 54 (58%) 
women (Schӧnnesson et al.).   
 Schӧnnesson et al. (2008) delineated behaviors by clusters not gender and found 
the mean use of crack in past 30 days per (a) highest risk cluster 56.77 times (range 1 to 
300), (b) consistent condom use cluster 44.63 times (range 1 to 300), and (c) inconsistent 
condom use cluster 27.47 (range 2 to 300). There were 44 (47%) participants in the 
inconsistent condom use cluster had identified no condom use ever compared to 18 
(16%) participants of the highest risk group.  When asked about the number of sex 
partners in the last 30 days, the highest risk cluster had an average of six sex partners 
compared to consistent condom use group who had an average of two to three sex 
partners, and the inconsistent condom use group had an average of one sex partner. The 
highest risk group reported trading sex for drugs an average of five times in the last 30 
days (Schӧnnesson et al.).  The highest risk group and inconsistent condom use group 
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reported having multiple sex partners and engaging in sex trade for drugs expose a high 
probability of transmitting HIV by sex (Schӧnnesson et al.). 
 Moreover, Schӧnnesson et al. defined serodiscordant as HIV positive participants 
who had unprotected sex with a HIV negative partner. The highest risk group of 49 
(24%) participants identified their partners as serodiscordant; in contrast the inconsistent 
condom use group identified 44 (35%) of partners as serodiscordant; and the consistent 
condom use group identified 64 (14%) of partners as serodiscordant. Schӧnnesson et al. 
concluded that crack cocaine smokers with HIV had a higher probability of transmitting 
HIV by sex.  
Drug Use Behaviors 
Drug users describe drug use behavior as a hobby, pastime, or diversion to cope 
with anxieties, which may result in friendships with other drug users who are described 
as a trusted relationship because of mutual interest in using drugs (Foster & Spencer, 
2013). Moshier et al. (2012) suggest that drug use behaviors stem from the user’s 
perception of belonging to a subculture of drug users who distinguish themselves as 
alienated from mainstream society and have a social connectedness because of bonds 
forged with other drug users. These bonds include a shared adventure and pleasure from 
using drugs or a feeling of purpose to procure drugs, provide drugs to others, make 
money, and avoid legal detention (Moshier et al.).  
Risky Sexual Behaviors  
In the conceptual model, a major factor in HIV transmission is engaging in risky 
sexual behaviors. Among African American women, the risk of being infected with HIV 
through heterosexual exposure is related to: (a) known risk behaviors and (b) unknown 
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risk behaviors (Jarama, Belgrave, Bradford, Young & Honnold, 2007). Known 
behavioral risks include trading sex, intravenous drug use, more than one sex partner in a 
year, diagnosis of STD, sexual partner with a history of incarceration, and sexual 
partner(s) not wearing condoms (University California San Francisco Centers for AIDS 
Studies, 2009).  Unknown risks can be characterized as a misperception of HIV risk 
behaviors; a woman’s perception is being in a monogamous heterosexual relationship but 
her sex partner is having outside sexual relationships (CDC, 2014; Jarama et al.). The 
woman may be unaware of her sex partner’s risk factors and may not perceive the need to 
use a condom or discuss sexual history with her partner (CDC, 2014). Although health 
departments have worked to educate the public about HIV risks, many African American 
women perceive themselves as low risk, especially if African American women believe 
they are in a monogamous relationship (Hobfoll, Jackson, Lavin, Britton, Shepherd, 
1993; Mallory, 2008; McNair & Prather, 2004).    
Jarama, Belgrave, Bradford, Young, and Honnold (2007) reported the unknown 
risk behavior among African American women is the result of trust in their partner. 
African American women are acculturated to not inquire about a partner’s sex history, 
negotiate condom use, or discuss sex in general (Harris et al., 2013; Jarama et al., 2007; 
Whyte, Whyte, & Cormier, 2008). Whyte et al. (2008) qualitative study illustrated the 
harm of poor communication about sexual history and unwavering trust in a relationship; 
African American women in this study describe their belief they were in monogamous 
relationship and found out differently after testing HIV positive, were “stunned by the 
diagnosis and its source” (p429); and reported husbands or partners were participating in 
down low sex meaning secret homosexual or bisexual sex. This lack of communication 
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regarding sexual history coupled with need to show trust, put African American women 
at unknown risk for contracting HIV infection (Corneille, Zyznieski, & Belgrave, 2008).  
There is evidence that men in general as well as African American men prefer to 
not use condoms related to the perception of: (a) diminished sexual pleasure, (b) lack of 
trust in the relationship, and (c) the impact on sense of male self  (Dodge, Jeffries, & 
Sanfort, 2008; Jarama et al.).  African American women’s inability to talk about sexual 
history, safe sex practices, or HIV testing with a partner prior to a sexual relationship puts 
the African American woman in a high risk category to become HIV infected (Harris, 
Mallory, & Stampley, 2010; Jarama et al.).   
For this investigation, having sex includes vaginal, oral, or anal sex. Based on this 
review of the literature, risky sexual behaviors include: number of sex partners, partner 
intravenous drug use, ever having a STD, and condom use.  
Number of Sex Partners  
 African American women are reported to have more lifetime sexual partners with 
increasing the risk of HIV infection and STDs than Latina women (Moreno, EI-Bassel, & 
Morrill, 2011). A comparative study of HIV/AIDS risk factors among Latina and African 
American women revealed African American women were 2.5 times more likely to 
report a STD than Latina women, and were 1.5 times more likely to report five or more 
sex partners in a lifetime (Moreno, El-Bassel, & Morrill, 2011). Senn, Carey, Vanable, 
Urban, and Sliwinski (2010) explored  African American relationships and predicted men 
will have more female sex partners as the male female ratio decreases in the census. In 
addition, Wright et al. (2007)  reported in a longitudinal study that African Americans 
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were twice as likely than Caucasians to report multiple sex partners in past 30 days (OR = 
2.5).  
Atkinson, Williams, Timpson, and Schӧnnesson (2007) studied the number of sex 
partners of African American males (n = 497) and females (n = 195) who had 
participated in vaginal sex within seven days prior to screening.  The average number of 
sex partners of the study participants for the past 30 days was 9.7 (SD = 16.9, Mdn = 5) 
and women had significantly more sex partners than men (Atkinson et al.).  Atkinson et 
al. also reported that 33 (17%) of African American women reported new sex partners 
prior to the study.  
Partner Intravenous Drug Use  
A woman’s sex partner, who uses intravenous drugs, is engaging in risky sexual 
behavior (CDC, 2014). Intravenous drug use (IDU) among African Americans is reported 
to be the cause of almost half of the HIV cases (CDC, 2013c). Additionally, the 2011 
HIV surveillance statistics report that IDU accounts for 46% of African American male 
cases (CDC, 2013e).     
Doherty, Schoenbach, and Admira (2009) used a cross-sectional design to 
describe the characteristics of African Americans in North Carolina infected with HIV 
classified as heterosexual transmission. Of the 276 women in the study, 78 were HIV 
positive and 148 were HIV negative; HIV positive women revealed 48% of their partners 
used illicit drugs compared to HIV negative women who reported 17% of their partners 
used illicit drugs (Doherty et al.).  In another descriptive study, Jenness, Neaigus, Hagan, 
Murrill, and Wendell (2010) examined the prevalence of relationships among non IDU 
having a sex partner that is an IDU. The sample included 601 subjects (256 men, 345 
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women) who had predominantly identified themselves as African American ([n = 472, 
78.5%]; Jenness et al.). Overall, 13.8% of the sample had a sex partner that was IDU; 
10.2% of the men and 16.5% of the women confirmed having sex with IDU (Jenness et 
al.).  Of the 472 African American, 13.6% confirmed having sex with IDU. Although 
gender was not differentiated by race or ethnicity, the important finding related to this 
investigation was that women were two times more likely than men in the study to have 
an IDU partner (Jenness et al.).  
Ever Having a Sexually Transmitted Disease  
In a comparative study of African American women and Latina women ever 
having a sexually transmitted disease (STD) as a risk factor for HIV, Moreno, Bassel, and 
Morrill (2007) reported African American women were two and half times more likely to 
report an STD compared to Latina women. Among the women (N = 1,128) who had 
sexual relations with a principal partner defined as main partner, African American 
women were more than twice as likely to have a partner with history of a STD and 1.6 
times more likely to perceive the principal partner’s sex behavior as risky (Moreno et al.).  
In Cavazo-Rehg et al. (2009) study of cocaine dependent individuals revealed 
25.6 % of African American women (n = 125) who traded sex identified as having ten 
sexual partners in past year and 55% of the women had past STD history, in comparison 
35.6% of the Caucasian women (n = 118) who had 10 sexual partners in the past year and 
35.3% had past history of an STD diagnosis (Cavazo-Rheg et al.). Decker et al. (2012) 
also noted that women who had a history of trading sex showed approximately one in a 
half the risk of ever having an STD; and in the last three months showed over twice the 
risk of having an STD (Decker et al.).  
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Condom Use  
According to the CDC (2013f, 2013g), use of latex condoms consistently and 
correctly is considered a reliable and effective measure in preventing HIV transmission as 
well as transmission of STDs. Condom use is when the male partner uses a condom when 
engaging in vaginal, anal, or oral sex with a female partner (CDC, 2013f, 2013g). 
Although African American women are knowledgeable about the transmission modes of 
HIV, their perception of actual risk is poor, for example, African American women’s 
knowledge of condom use to prevent HIV infection is good, but evidence has shown 
inconsistent use of condoms (Nunn et al., 2011; Mallory, Harris, & Stampley, 2009).  
Corneille, Zyzniewski, and Belgrave (2008) performed a cross-sectional study on 
initial data collected from African American unmarried heterosexual women (N = 325) 
aged 18 to 61 years who participated in the five week Sistas Informing Sistas about the 
Topic of AIDS (SISTA) program. Multiple regression and logistic regression analysis 
were used to detect the influence of age and length of relationship on (a) condom use, (b) 
intention of condom use, and (c) attitudes towards condom use (Corneille et al.). The 
findings suggest older African American women may be at greater risk for HIV because 
they perceived their principal partner as being opposed to condom use (Corneille et al.). 
Younger African American women were more likely to use condoms in current or past 
relationships; yet all women reported they were less likely to use condoms with their 
principal partner (Corneille et al.). 
Moreno et al. (2007) reported in a comparative study of the HIV risks among 
African American women and Latina women (n = 1,298) who had sexual intercourse 
with their principal partner in the past 30 days; 359 (65%) of African American women 
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replied no to condom use and 197 (35%) replied yes.  African American women 
responded to the frequency of condom use was 108 (55%) as some of time and 88 (45%) 
all the time (Monroe et al.). Although African American were twice as likely as Latina 
women to use condoms with their principal partner (OR = 1.78, 95% CI [1.32, 2.40]), 
African American women were twice as likely as Latina women to perceive their 
principal partner as having risk factor for HIV (OR = 1.59, 95% CI [1.15, 2.20]; Moreno 
et al.).  
Trading Sex Behaviors 
Sex trading for this investigation is defined as trading sex for money, drugs, 
alcohol, food, or a place to stay. Dolwick-Grieb, Davey-Rothwell, and Lakin (2012), in a 
study sample of 567 African American women, reported that over the past 90 days 375 
(66.1%) of the women traded sex to obtain drugs.   
Millay et al. (2009) studied women who traded sex, had identified selves as 
“hooker, hustler, working girl, and street walker (p. 813)”. The women negotiated for 
money from male customers who requested sex, commonly agreed to vaginal or oral sex. 
They described receptive anal sex as a least desirable transaction but if receptive anal sex 
was agreed upon an increased payment was normally negotiated (Millay et al.). The 
money accrued was used to pay financial obligations or to support drug use (Millay et 
al.).    
Decker et al. (2012) showed African American women that were more likely to 
trade sex compared to Caucasian women and Hispanic women; and immigrant women 
were less likely to trade sex. Cavazos-Rheg et al. (2009) included 243 women in the 
study that were cocaine dependent, Caucasian women (n = 118) and African American 
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women (n = 125).  The findings showed that African American women (62.4%, n = 78) 
traded sex for drugs and/or money compared to Caucasian women (40.2%, n = 47) traded 
sex for drugs and/or money (Cavazos-Rheg et al.). 
A longitudinal study examining HIV risk behaviors among rural drug users found 
of the 266 women, 100 (37.6%) reported trading sex for money or drugs (Wright et al. 
2007).  Rural African American women were more likely to trade sex for money or drugs 
(44.7%) compared to 19.7% of Caucasian women (AOR = 1.7) (Wright et al. 2007).  
 Semple, Strathdee, Zians, and Patterson (2011) examined 342 subjects with a high 
risk sex behavior for trading sex for methamphetamine; 176 (51.5%) were females.  In 
this study women were twice as likely as men to trade sex for methamphetamine (AOR= 
1.77, 95% CI [1.08, 2.89]), be binge methamphetamine users (AOR = 2.33, 95% CI 
[1.25, 4.37]), and trade sex as non-binge methamphetamine users (Semple et al.).  The 
authors also noted that sex trading was associated with high risk HIV sex behaviors in 
those having 24 or more anal sex acts in the last two months (OR  =  3.04, 95% CI [1.27, 
7.15]) and forced or coerced sex in last two months (OR = 3.19, 95% CI [1.45, 6.99]).  
A cross sectional study of women (N = 1277) visiting family planning clinics in 
North Carolina compared sexual risks of women who traded sex and women who did not 
trade sex (Decker et al., 2012) . Women who traded sex showed that risk tripled for 
having multiple current sex partners, and showed the risk doubled for engaging in anal 
sex and for having more than two partners (Decker et al.).  Women who traded sex were 
five times the risk to be a victim of unwanted anal sex and at three and half times risk for 
unwanted vaginal sex (Decker et al.).  Sex trade was also associated with an increased 
risk of unintended pregnancy and increased abortion (Decker et al.). STDs, unwanted 
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pregnancy, or unintended plan to abort were the consequences of risky sexual behavior 
described by Decker et al.  
Attitudes about HIV/AIDS and Risky Sexual Behavior 
 Attitudes are a person’s beliefs, the ways of thinking that influences the person’s 
behavior (Merriam-Webster Inc., 2014). For this study, attitudes are personal beliefs or 
opinions about contracting HIV/AIDS and beliefs regarding risky sexual behavior. Based 
on a review of the literature presented in this section cultural stereotypes and risky sexual 
attitudes, attitudes about the use of condoms, and attitudes about drugs are described.  
Cultural Stereotype and Risky Sexual Attitudes 
Duvall et al. (2013) studied 206 African American women and examined the 
association of complimentary sexual stereotypes on risky sexual attitudes and behaviors. 
The Complimentary Sexual Stereotypes (CSS) Subscale of Multidimensional Racial 
Attitude Scale was used to measure cultural stereotype attitudes, and risky sexual 
attitudes were measured using the Reducing Risky Relationships Thinking Myths Scale 
(RRR-TMS) (Duvall et al.).   
The five item CSS subscale measured responses on seven point Likert scale and 
ranged from strongly disagree to strongly agree. Responses were computed and averaged 
to create a measure ranging from 0 to 6, and an item average was used in place of a total 
score to allow for the interpretation and of the multivariate regression analysis (Duvall et 
al., 2013). Sample items on the CCS subscale include: “Black men give off an aura of 
sexuality” and “Black people have a unique quality of sexuality that most white people 
don’t have” (Duvall et al., p. 7). The 12 item RRR-TMS measured the magnitude of 
participating in risky sexual behavior and drug use on relationship status. Responses were 
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measured significantly and positively on a 10 point scale ranging from definitely true to 
definitely not true, and a higher score indicated riskier sexual attitudes (Duvall et al., 
2013).  Examples reflect risky sexual attitudes: “Having sex without protection will 
strengthen my relationship”, and “I only think good things about myself when I am in a 
relationship, even if it is risky relationship” (Duvall et al., p.7).   
Duvall et al. (2013) reported age (X = 36.6, SD = 14.2) had a positive relationship 
with risky sexual behaviors (r = .14, p < .05).  The analysis indicated that African 
American women in the sample had a significant positive association with cultural 
stereotype attitudes and attitudes of sexual risk (B = .25, SE = .09, p < .01) (Duvall et al.). 
The number of partners was significantly and positively associated on the CCS (r = .46, p 
< .01) as well as trading sex for money (r = .16, p < .01); the number of casual sexual 
partners revealed a significant relationship agreeing with cultural stereotype attitudes (B 
= .29, SE  =  .15, p < .01) (Duvall et al.).  Duvall et al. concluded that complimentary 
sexual stereotypes could lead to increased sexual risk behavior, which may lead to HIV 
infection. 
Duvall et al. (2013) also reported that African American women (N = 206) who 
traded sex for money, drugs, or favors showed a significant relationship with 
complimentary sexual stereotypes (B  = .78, OR = 2.18, SE = .34, p < .05). The results 
indicated that, among African American women, there is an association between racial 
sexual stereotypes and the act of trading of sex (Duvall et al.).  The importance of this 
finding is that risky sexual behaviors may be influenced by the African American 
women’s affirmation of racial sexual stereotype beliefs (Duvall et al.).  Moreover, racial 
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sexual stereotype beliefs may be an extenuating factor influencing HIV risky behavior 
among African American’s women (Duvall et al.).   
In an exploratory study by Jarama, Belgrave, Bradford, Young, and Honnold 
(2007) of 51 African American women aged 18 to 49 years, the women all believed they 
had control within their sexual relationship and voiced assurance of being comfortable to 
discuss safer sex with partners. Of the 51 women, 36 (70%) reported inconsistent condom 
use, and 22 (43%) reported not discussing safer sex with partner. Themes that emerged 
for not discussing safer sex with their partners included trust and the belief that God 
would protect them from harm (Jarama et al.). Although all of the women perceived HIV 
risk as minimal, Jarama et al. noted during the semi-structured interviews that all of the 
women acknowledged that there was an identifiable HIV risk.  Jamara et al. concluded 
this sample of African American women had a moderate risk for HIV by generalizing 
participants’ comments and responses that revealed identifiable risk factors among the 
women’s sexual partners.  
Attitudes about Use of Condoms  
 Attitudes among African American women about condom use are important and 
related to HIV risk. Corneille, Zyzniewski, and Belgrave (2008) assessed condom 
attitudes among 325 African American women aged 18 to 61 years. Corneille et al. used 
a seven item Likert attitude scale ranging from strongly disagree to strongly agree to 
measure participants’ attitude about using condoms and perception of partner’s attitude of 
about using condoms that found a participants’ mean score of 1.76 (SD = 0.7), which 
reflected a slightly negative attitude towards condom use.   
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 Duvall et al. (2013) in a study of African American women found frequency of 
condom use (r = -.26, p < .01) was negatively associated with age and marital status  
(r = -.19, p < .01).  African American women believed their relationship was reinforced 
by not having their partner use condoms ([B = .28, SE = .10, p < .01]; Duvall et al.).  
Likewise, participants’ perception of partners’ attitude toward no condom use as 
reinforcing their relationship showed a similar mean score of 1.79 (SD = 0.59) with 
greater deviation of a negative attitude towards condom use (Duvall et al.).   
Corneille et al. (2008) studied the influence of age on participants’ perceptions of 
their partners’ attitude towards condom use controlling for education, partner status, 
length of relationship and found when the women’s age increased, perception of partner’s 
attitude towards condom use decreased.  Age impacted the women’s perception of 
partners attitudes about condom use, when the women’s age increased their perception of 
partner’s attitude towards condom use decreased. Length of relationship and level of 
education were significantly associated with the women’s perception of their partners 
attitudes towards condom use, women with college or some college education perceived 
partner’s attitudes towards condom use as more positive and women in a longer 
relationship were more likely to have reported a decrease in partner’s approval to wear 
condoms (Corneille et al.).   
 Belgrave, Corneille, Hood, Foster-Woodson, Fitzgerald (2010) studied 398 
unmarried, heterosexual, African American women to determine attitudes towards 
condoms and drugs.  Attitudes about condom use were measured using a seven item 
questionnaire with a four point Likert scale with questions like:  “Sex with condoms does 
not feel natural” (Belgrave et al., p. 133).  A higher score indicated an unfavorable 
 Green, Lisa, UMSL 36 
 
attitude toward condom use; condom attitudes had a mean of 1.73 (SD = .54) on pretest 
and a posttest HIV intervention mean of 1.59 (SD = .46) (Belgrave et al.).  
A qualitative study explored HIV beliefs, attitudes, feelings, and behaviors among 
a convenience sample of 36 African American Midwestern women primarily professional 
(78%) aged 40 to 65 years using focus groups and interviews (Harris, Mallory, & 
Stampley, 2013). The theme of man sharing, defined as two women residing at two 
different residences knowingly have a committed intimate relationship with one man 
during the same time period, surfaced during interviews with 15 of 21 participants (Harris 
et al.). African American women in the study noted that the practice of man-sharing is 
due to lack of acceptable and available African American men stemming from: (a) 
incarceration, (b) intravenous drug use, (c) down low (secret homosexual or bisexual 
behavior), and (d) dating women outside the African American race (Harris et al.). These 
women described the restricted belief of not being able to negotiate safe sex practices for 
fear the man would terminate the relationship and initiate relationship with another 
woman, and viewed man sharing as risky, dangerous, and a contributing factor to 
increase incidence of HIV among middle age African American women (Harris et al.).    
Attitudes about Drugs  
Belgrave et al. (2010) hypothesized that African American women who sensed 
the presence of group social support were likely to have an increase condemnation of 
drug use and had a greater awareness of the dangers of drug use. In addition, Belgrave et 
al. hypothesized that African American women would report on post-test lower use of 
alcohol and marijuana.  Belgrave et al. surveyed 398 African American women who 
attended three out of five HIV prevention classes and then administered an instrument 
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that measured both their disapproval and perception of harm using alcohol, marijuana, 
and tobacco.  Perception of drug harm was measured with a four item Likert scale 
examining participants’ attitudes about drugs:  “How much do people risk harming 
themselves when they smoke marijuana once a month” (Belgrave et al., p. 134).  The 
results showed a 7% decrease in alcohol use from pre-test to post-test; marijuana use 
showed no change from pre-test to post-test; and the tobacco use was not reported 
(Belgrave et al.). The participant results on post-test showed an overall 1% increase in 
disproval of alcohol, marijuana, and tobacco use; and 2% increase in perception of the 
drug harm with alcohol, marijuana, and tobacco use (Belgrave et al.).  These findings 
suggest that a perceived social support has a limited association with disapproval and 
perception of harm with alcohol, marijuana, and tobacco use (Belgrave et al.). 
Knowledge about Actions to Prevent HIV or STDs 
 Knowledge is defined as having a general awareness or possession of information 
facts, truths, or principles (Merriam-Webster Inc., 2014). Important to this investigation 
is knowledge about actions taken before and after intercourse to prevent HIV. Shamley–
Ebron (2009) used focus group interviews and participatory observation while providing 
an eight week culture, gender oriented HIV prevention intervention to explore eight 
young African American girls’, aged nine to twelve years, knowledge of body and sexual 
health. Shamley-Ebron found the girls lacked knowledge about reproductive body 
processes or sexual health and were unable to identify actions needed to consummate sex 
or sex behaviors that transmitted disease.  The next theme to emerge was the girls’ 
inaccurate reproductive knowledge, body knowledge, and sexual health.  Shamley-Ebron 
illustrated lack of knowledge about sexual health with the girl’s desire for knowledge 
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with a participant’s quote: “… My mother just told me not to bring home any babies, but 
she did not tell me how it happens … just don’t hang around with boys because they are 
nasty” (p.33).    
 Kennedy and Roberts (2009) in a mixed-method study explored STD and HIV 
knowledge among 15 young women (11 African American, 2 Hispanic, 2 Samoan) aged 
18 to 24 years using a 27 item STD knowledge questionnaire with internal consistency (α 
= .86) and an 18 item HIV knowledge questionnaire with internal consistency (α = .79 - 
.89). The mean score for the sample on STD knowledge test was 59%, and the mean 
score on HIV knowledge test was 73% (Kennedy & Roberts). Participants expressed 
frustration with their high school sex education, which included only sex abstinence, not 
having an adult woman in their life willing to discuss sex, and a desire to have someone 
to discuss sex with and the ability to have questions answered truthfully (Kennedy & 
Roberts).   
Younge, Salem, and Bybee (2010) studied 196 low income African American 
women with a mean age of 30.38 (SD  =  9.34) and measured their HIV knowledge using 
a 24 true/false item HIV/AIDS knowledge scale that identified acts before and after sex 
to prevent HIV/STDs developed specifically to be used with African American women. 
The women answered an average of 82% of the true/false questions (Younge et al.). 
Young et al., asked participants about actions they took to prevent HIV/STDs before and  
after sex and reported the participants responses: (a) 127 ( 65%) used condoms, (b) 49 
(25%) practiced monogamy, (c) 25 (13%) had routine HIV testing, (d) 19 (10%) douched 
or washed after sexual intercourse, (e) 19 (10% ) knew partner was HIV negative, (f) 10 
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(5%) took birth control, (g) 7 (4%) partner pulled out before ejaculation, and (h) 1 (.5%) 
substituted oral or anal sex for vaginal sex (Young et al., 2010).  
HIV Testing 
An HIV test is used to detect the HIV/AIDS virus (CDC, 2014b). In 2006 the 
CDC modified HIV testing guidelines as a result of an increase HIV incidence among 
persons unaware of HIV status and those who may not appear to belong to high risk 
categories such as sex trading, IDU, and men who have sex with men (MSM), etc. 
(CDC,2006).  The 2011 HIV Surveillance Report revealed N = 50,007 new cases of HIV 
infection; heterosexual exposure accounts for 12% (N = 4,775) of the HIV infections 
among males, and 86% (N = 9,026) of the HIV infections among females (CDC, 2013f).  
The accumulated total of heterosexual exposure is extracted from the CDC 2011 
surveillance report by calculating the sum of HIV cases among females and males 
exposed by heterosexual relation and then dividing by the cumulative total of HIV cases. 
Heterosexual contact accounts for all HIV cases are 27.6% (N = 13,801); yet it accounts 
for 63% of the cases among African American women.  
HIV Status Awareness 
The CDC (2008) reported an estimate of the number of undiagnosed people with 
HIV to be 21.0% to 25.0% (232,700 to 312,000). Marks, Crepaz, and Janssen (2006) 
calculated that 54% of new HIV cases each year are result of sexual transmission by 
those persons who are unaware of their HIV status. According to Marks et al. persons 
who are unaware of their HIV positive status are 3.5 times higher than those aware of 
HIV positive status to sexually transfer the virus.  Marks et al. (2006) theoretically 
proposed that if 57% of those persons undiagnosed HIV became aware of their HIV 
 Green, Lisa, UMSL 40 
 
positive status these persons would avoid unprotected anal and vaginal intercourse and 
could decrease new HIV sexual transmissions by 31%.   
Early HIV Detection     
 Early detection of HIV can result in the initiation of antiviral medications to 
maintain CD4 counts and decrease presence of serum viral load (Department of Health 
and Human Services [HHS], 2009, 2011). The decreased viral load can diminish the 
probability of transferring the virus to another person as well as decreasing the risk for 
opportunistic infection (Castilla et al., 2010; Donnell et al. 2010; Lingappa, 2010; Quinn 
et al. 2000; Wilson, Law, Grulich, Cooper, & Kaldor, 2008). There is also evidence that 
initiation and adherence to antiretroviral medications can reduce viral load 1,500 
copies/ml or undetectable (Donnell, 2010; Quinn et al., 2000). Evidence has shown that 
low to undetectable viral load can prevent the transferring of the virus (Castilla et al., 
2010; Donnell et al. 2010; Lingappa, 2010; Quinn et al. 2000; Wilson, Law, Grulich, 
Cooper, & Kaldor, 2008). With the increase awareness of HIV status and the initiation of 
antiretroviral medications, the HIV incidence rates may be decreased. Most important, 
awareness of HIV disease can provide initiation of antiretroviral therapy to halt the 
progression of the disease and prevent death. 
HIV Screening 
 Screening for HIV was initially developed in 1985 to prevent the contamination 
of the blood supply (CDC, 1985). There are approximately 50,000 new cases of HIV 
reported each year in the U.S (CDC, 2013f). The true prevalence of HIV virus is 
unknown. As of 2009 the CDC (2010) noted that 82.9 million of adults  aged 18 years 
and over in the U.S. reported they had never been tested for HIV, which is approximately 
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36% (N = 230,118 million [U.S. Census, 2010].  In 2001, the CDC recommended routine 
HIV screening in urban and rural areas with high prevalence of HIV to be provided by 
the public and private venues that offer HIV counseling, referral, and treatment. In areas 
with low prevalence of HIV, the private and public health care settings were to screen for 
high risk behaviors (CDC, 2001). If high risk behaviors were noted, HIV screening was 
recommended (CDC, 2001).   
HIV Tests 
The need to develop tests to detect HIV as quickly as possible became a priority. 
The Henry J. Kaiser Family Foundation (2006) reported the history of HIV test 
development, which follows:  
1. The first HIV test, the enzyme linked immunosorbent assays (ELISA), was 
introduced in 1985. The Western Blot blood test kit was developed in 1987. 
2. Rapid HIV test, Murex Single Use Diagnostic System (SUDS) was introduced in 
1992 (Park C. & Arens M., 1993). 
3. The oral fluid HIV test was developed in 1994. 
4. The home urine HIV test was developed in 1996. 
5. Rapid HIV test requiring whole blood sample per finger prick was introduced in 
2002. 
6. Clinical laboratory improvement amendment (CLIA) provided a waiver to allow 
the HIV rapid finger testing to be administered outside the conventional 
laboratory by persons without official laboratory training in 2003. 
7. In 2004 the CLIA provided a similar waiver for the rapid oral fluid test. 
Each of these tests is presented below: 
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ELISA  
The HIV test, enzyme linked immunosorbent assays (ELISA), binds blood serum 
HIV antibodies with HIV antigens (University of Arizona, 2000). The HIV positive 
results have an optical density, concentration of viral proteins, of 0.500 nanometer (nm) 
(University of Arizona, 2000). A nanometer is a unit measurement of one billionth of a 
meter. An optical density below 0.300 nm is considered negative, and 0.300 to 0.499 is 
considered indeterminate (University of Arizona, 2000). A false negative can be related 
to the time between infection and antibody response to the virus that is not yet detectable 
(University of Arizona, 2000). If test is positive there is a need to confirm the results with 
a second test to rule out technical error (University of Arizona, 2000). 
Western Blot-test Kit   
The Western Blot is performed using blood serum and is considered the 
confirmatory test (University of Arizona, 1998). The Western Blot allows for the 
visualization of viral antibodies against each viral protein (University of Arizona, 1998). 
The HIV proteins being tested are: (a) glycoprotein (gp)160 (viral envelope precursor), 
(b) gp120 (viral envelope protein that binds to the CD4), (c) protein (p) 24 (viral core 
protein), and (d) p 31 (reverse transcriptase) (University of Arizona, 1998). If the test is 
positive there will be two bands present in agreement with the following criteria: (a) band 
present for either p 31 or p 24, and (b) band present for either gp 160 or gp 120 
(University of Arizona, 1998). If bands are present, but the pattern is not in agreement 
with criteria for a positive result, then the test result is considered indeterminate and if 
there are no bands, the test is negative (University of Arizona, 1998).  
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Rapid HIV Tests 
The development of rapid HIV tests provided an inexpensive way to screen at risk 
individuals for HIV.  Many of these tests were Clinical Laboratory Improvement 
Amendments (CLIA) waived. Congress passed the CLIA of 1988 to categorize laboratory 
tests according to complexity as (a) waived, (b) moderate complexity, and (c) high 
complexity (FDA, 2009). The CLIA waiver is provided for a simple laboratory test that 
can be administered by a person with minimal training to achieve accurate results to lead 
to diagnosis of HIV (FDA, 2009). All FDA approved home tests are CLIA waived (FDA, 
2009). These tests furnished community based organizations the ability to offer HIV 
testing to at risk populations, with minimal access to health care (Greenwald, Burnstein, 
Pincus, & Branson, 2006).  The main advantage of rapid tests was the ability to provide 
immediate results for an individual in comparison to the HIV tests that took longer and 
often resulted in an inability of locating individuals to report results to (Greenwald et al.). 
Rapid testing provided the potential for the expansion of testing to reach greater numbers 
of individuals who are unaware of their status and who had not yet presented with signs 
and symptoms of HIV (Greenwald et al.).    
 There are a variety of approved Federal Drug Administration (FDA) rapid tests. 
The rapid test screens for circulating HIV antibodies and has shown high sensitivity and 
specificity. Following are the FDA approved rapid tests (Health Research and Education 
Team, CDC, 2008). 
OraQuick Advance Rapid HIV 1/2 Antibody 
The OraQuick Advance Rapid HIV 1/2 Antibody test was approved by the FDA 
in November 2002 (Health Research Education Team & CDC, 2008).  This test is 
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performed with (a) oral fluids from the mucosal transudate  the cheeks and gums has 
sensitivity of 99.6% (98.5 - 99.9) and specificity of 99.8 (99.6 - 99.9), (b) whole blood 
via finger stick or venipuncture has a sensitivity of 99.6% (98.5 - 99.9) and specificity of 
100% (99.7 - 100), and (c) plasma has sensitivity of 99.6% (98.5-99.9) and specificity of 
100% (99.6 - 99.9) (Health Research Education Team & CDC, 2008). The oral fluid and 
whole blood specimens are CLIA waived and the test with plasma is categorized by 
CLIA of moderate complexity (Health Research Education Team & CDC, 2008). 
Uni-Gold Recombingen HIV 
The Uni-Gold Recombingen HIV rapid test was approved by the FDA in 
December 2003 (Health Research Education Team & CDC, 2008). The test can be 
performed with whole blood via finger stick or venipuncture and has a sensitivity of 
100% (99.5 - 100) and specificity of 99.7% ([99.0 - 100]; Health Research Education 
Team & CDC, 2008). This test can also be performed with serum and plasma specimens 
and has a sensitivity of 100% (99.5 - 100) and specificity of 99.8% ([99.3 - 100]; Health 
Research Education Team & CDC, 2008). The test using whole blood specimen is CLIA 
waived, but serum and plasma is categorized as moderate complexity (Health Research 
Education Team & CDC, 2008). 
Reveal G3 Rapid HIV-1 Antibody Test 
The Reveal G3 Rapid HIV-1 Antibody rapid test was approved by the Federal 
Drug Administration (FDA) in April 2003 and is CLIA categorized as moderate 
complexity (Health Research Education Team & CDC, 2008). This test can be performed 
with a serum specimen and has a sensitivity of 99.8% (99.2 - 100) and a specificity of 
99.1% ([98.8 - 99.4]; Health Research Education Team & CDC, 2008).  Testing with a 
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plasma specimen has a sensitivity of 99.8% (99.0 - 100) and slightly lower specificity of 
98.6% ([98.4 - 98.8]; Health Research Education Team & CDC, 2008). 
MultiSpot HIV-1/HIV-2 Rapid Test 
The MultiSpot HIV-1/HIV-2 rapid test was approved by the FDA in November 
2004 and has a CLIA category of moderate complexity (Health Research Education 
Team & CDC, 2008). The test can be performed with a serum or plasma specimen. The 
serum and plasma specimens have a sensitivity of 100% (99.4 - 100). The specificity of 
serum is 99.93% (99.79 - 100), and the specificity of plasma is 99.91% ([99.77 - 100]; 
Health Research Education Team & CDC, 2008). 
Clearview HIV ½ STAT-PAK 
The Clearview HIV ½ STAT-PAK rapid test was approved by the FDA in May 
2006 is CLIA waived and can be performed using whole blood specimens via a finger 
stick or venipuncture (Health Research Education Team & CDC, 2008). The whole blood 
specimen has a sensitivity of 99.7% (98.9 - 100) and a specificity of 99.9% ([99.6 -100]; 
Health Research Education Team & CDC, 2008). The test can also be performed using 
serum and plasma specimens that are CLIA non-waived and reveal a sensitivity of 99.7% 
(98.8-100) and a specificity of 99.9% ([99.6 - 100]; Health Research Education Team & 
CDC, 2008). 
Clearview Complete HIV ½ 
The Clearview Complete HIV ½ was FDA approved in May 2006 (Health 
Research Education Team & CDC, 2008). The test specimens are (a) whole blood via 
finger stick or venipuncture with CLIA waiver, and (b) plasma or serum and are CLIA 
non-waived (Health Research Education Team & CDC, 2008). The specimen types yield 
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the same sensitivity of 99.7% (98.9-100) and specificity of 99.9% (99.6-100) (Health 
Research Education Team & CDC, 2008). 
Calypte
TM
 HIV-1 Urine EIA test for HIV 
The Calypte
TM
 HIV-1 Urine EIA test for HIV was FDA approved in 1996 and is 
an immunoassay test that detects HIV recombinant gp 160 envelope in the urine (FDA, 
2000). Clinical studies yielded sensitivity between 94.5% and 96.7% and specificity 
78.3% and 80.8% (FDA, 2000). This test has less sensitivity to HIV antibodies and 
greater false positives compared to other rapid tests using oral fluids, whole blood, serum, 
or plasma. Since the advancement of rapid HIV tests, the urine test is generally not used 
in the U.S. (San Francisco AIDS Foundation, 2009). The Calypte
TM
 HIV Urine EIA test 
has been marketed and distributed to Brazil, Canada, China, Egypt, England, France, 
India, Italy, Ivory Coast, Japan, Malaysia, South African, South Korea, Spain, and 
Uganda (FDA, 2000). The urine test is used more, accepted, and utilized by cultures that 
have cultural issue with providing a blood specimen (San Francisco AIDS Foundation, 
2009). 
Counseling if HIV Positive 
Rapid HIV tests allows individuals to receive results in 20 to 30 minutes. 
According to the CDC (2006), rapid testing provides a method to increase HIV screening. 
The CDC (2006) claimed HIV prevention counseling in the acute health care setting may 
be seen as a barrier to testing and can interfere with HIV screening and diagnostic testing.  
Although counseling may be seen as a barrier, the CDC (2007) endorsed that HIV 
education with prevention measures be provided to individuals in the health and 
community settings caring for populations at high risk for HIV. 
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Prior to testing the individual should be informed that if HIV rapid test is reactive, 
a confirmatory testing will be needed (CDC, 2007). Counseling prior to an HIV rapid test 
is outlined by the CDC (1999) RESPECT-2. The counselor’s focus is to assist with 
identifying personal HIV risks and creating an individualized risk reduction plan (CDC, 
1999). After testing, a simple explanation of test results is provided and the HIV risk 
reduction plan is reviewed. If test is HIV positive, the person is reminded that there is a 
need for confirmation testing and assistance with identifying sources of support and 
making referrals as necessary (CDC, 1999, 2007). If the individual is negative, there is a 
need to provide education regarding a potential false negative. A false negative can 
happen if the test is performed during the window period, the time when the virus is in 
the body but HIV antibodies cannot be detected (Gallagher, 2010).  The individual should 
be advised to have a follow up test in three months (CDC, 2007). At the follow up 
testing, it is important to review the person’s individualized risk reduction plan while 
prompting the person to recognize any perceived barriers to the risk reduction plan (CDC, 
1999).  
Opt-in HIV Testing  
 The CDC (2001) recommended that HIV testing be offered to patients in health 
settings where the prevalence of HIV is greater or equal to 1%. Opt-in HIV testing is a 
targeted screening of patients who self-identify one or more HIV risks on a condensed 
HIV risk survey tool of five items (CDC, 2001). The patient is then counseled on HIV 
transmission, HIV prevention methods, the meaning of a HIV test, and the importance of 
obtaining HIV test results (CDC, 2001). With opt-in testing, the patient must provide 
informed consent before HIV testing is performed (CDC, 2001).   
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Opt-in Testing and Acceptance  
Merchant, Seage, Mayer, Clark, DeGrutolla , and Becker (2008) studied 
acceptance of  opt-in HIV testing among patients aged 18 to 55 years who visited the 
New England emergency department from July 2005 to July 2006. Merchant et al. 
reported less acceptance of opt-in HIV testing among adults (a) over 45 years, (b) men, 
(c) Caucasians, (d) persons with private insurance, (e) married, never married, or (f) no 
partner. Patients who were more likely to accept opt-in HIV testing were (a) Hispanic and 
African Americans with less than 12 years education, (b) previously HIV tested, and (c) 
no insurance or government insurance of Medicaid/Medicare (Merchant et al.). They 
reported the core reasons for accepting opt-in HIV testing were to obtain knowledge of 
HIV status and concern about possible HIV exposure.  The chief reasons cited for 
declining opt-in HIV testing were perceived belief of not being at risk for HIV and 
previously being mandated to HIV test, such as requirement of marriage, health 
insurance, military, or incarceration (Merchant et al.). The study has a limitation of not 
appraising the perceived and actual HIV risk factors of the participants. 
Merchant et al. (2008) also reported that, of the 2,099 study participants, 935 
(44.6%) had never tested, 1,144 (54.5%) had a previous HIV test, and 39% of all study 
participants agreed to rapid HIV opt-in testing.  Of the 935 participants who were never 
tested, the participants reasons for not testing: (a) 56.2% did not perceive themselves at 
risk, (b) 29.6% had not contemplated testing, (c) 6.4% reported testing angst, (d) 4.4% 
viewed testing as inconvenient, and (e) 3.5% reported other (Merchant et al.). Participants 
aged 25 to 29 years had the greatest acceptance of opt-in HIV testing (44.5%). In 
contrast, participants aged 45 to 49 years were less accepting of opt-in HIV testing 
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(30%); 39.0% of women accepted and 39.5% of the men accepted HIV opt-in testing; and 
Hispanics (54.6%), African American (43.6%), Caucasian (36.1%), and other (42.3%) 
accepted HIV opt-in testing (Merchant et al.). Participants with a high school education 
or less were twice as likely than participants with higher education to accept HIV opt-in 
testing because of apprehension about HIV exposure (OR = 2.29, 95% CI [1.35, 3.88]); 
and participants with high school education or less were twice as likely than those with 
higher education to decline opt-in HIV testing because of recent HIV testing (OR = 1.74, 
95% CI [1.15, 2.64]; Merchant et al.).  
Opt-out HIV Testing 
In 2006, the CDC (2006) changed its recommendation of opt-in HIV testing to 
opt-out HIV testing, which should be performed in all settings with greater or equal to 
1% prevalence per 1,000 patients screened for HIV.  Opt-out HIV testing is offered to all 
patients regardless of HIV risk as part of routine care unless the patient declined testing 
resulting in the opt-out of HIV testing designation (CDC, 2006). This change to opt-out-
testing was a result of barriers with opt-in testing. For example, health care providers did 
not always have the personnel or time to provide HIV risk screening and the required 
counseling, informed consent was needed, and HIV testing was often not reimbursed by 
insurance companies because it was not deemed routine care (CDC, 2006).  The 
advantages of opt-out HIV testing was the patient’s initial signing of consent for 
treatment during routine admission paperwork, which covered HIV testing and no 
additional informed consent was needed for HIV testing (unless otherwise mandated by 
state law of the residing health facility), and the test was reimbursable by insurance 
companies because it became a part of routine care (CDC, 2006).  Additionally, the CDC 
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(2006) by changing opt-in to opt-out HIV testing increased awareness of HIV among 
individuals with unknown risk status, and maybe result in earlier care for patients with a 
HIV positive test.  
HIV Opt-out-testing and Acceptance   
 Opt-out HIV testing has been recommended by the CDC 2006 guidelines, yet 
there are few studies showing the efficacy of the recommendations. Brown et al. (2008) 
was among the first studies to investigate patient acceptance of routine HIV opt-out-
testing at an emergency department (ED) with an high HIV prevalence.  A convenience 
sample of 9,826 participants from an ED revealed HIV testing acceptance of 53% (N = 
5,223) and an HIV testing rejection of 47% (N = 4,594).  According to Brown et al. 
African American self-identified as being HIV positive (6.1%) was higher than of all 
other races/ethnic backgrounds (0.8%). When comparing percentage of HIV test 
acceptance rates within a homogenous group, African Americans (55%) accepted HIV 
testing compared to Caucasians (52%), Hispanics (50%), and Asians (42%).  A study be 
Brown et al. indicated African Americans were (a) more likely to accept HIV testing, (b) 
less likely to reject a test due to low risk perception, and (c) more likely to provide the 
response for test rejection as having a recent HIV test or belief of perceived low risk.   
Freeman et al. (2009) studied opt-out-testing among patients aged 13 to 64 years 
at a Georgia hospital. Of the 5,080 patients invited to participate in the study, 91% agreed 
to HIV testing. Among the participants, the study revealed high agreement to be HIV 
tested.  It needs to be recognized that 11% of the eligible patient population were offered 
HIV testing. The study design outlined specific time parameters for HIV testing to take 
place per study protocol, five days a week and during a 10 hour day shift. Outside the 
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study’s protocol recognized parameters of time and day, there were 73 (.16%) patients 
HIV tested.   
Freeman (2009) identified 29 patients with positive HIV rapid tests, and 26 
confirmed tests performed via Western Bloc test. Of the patients tested, 2% (N = 112) 
were identified as having high risk behaviors for HIV.  Although age and race were not 
considered significant variables in predicting high risk behavior, the return rate of HIV 
assessment survey was 2%, too low to make inferences related to socio-demographic 
variables. Freeman et al. reported 98% of the sample did not complete HIV risk 
assessment. Of the surveys completed, 3% (N  =  62) of the men and 2% (N = 60) of the 
women had high risk HIV behaviors, males were more likely to report high risk behavior 
than females (OR = 1.83; 95% CI [1.23, 2.72]), and African Americans (92%) were more 
likely to accept HIV testing compared to Caucasians (89%) (Freeman et al.). Overall 
Freeman et al. found that African American, older patients, and unmarried patients were 
more likely to seek HIV testing compared to Caucasian, pediatric patients, and married 
patients. Findings of Freeman et al. (2009) and Myers et al. (2009)  findings were similar 
findings by Brown et al. that African Americans are more likely to accept HIV testing 
with HIV opt-out-testing.  
Myers, Modica, Dufour, Bernstein, and McNamara (2009) evaluated six 
community health Centers serving high risk populations for HIV screening between 
March 1, 2007 and March 31, 2008 and  reported high acceptance of HIV opt-out-testing 
when HIV testing was offered. Of the 58,619 patients in the community centers 16,148 
(28%) were offered rapid HIV testing and 10,769 (67%) accepted rapid HIV testing 
(Meyers et al.). The rapid HIV test yielded 39 positive tests and 17 of the positive tests 
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were confirmed with the Western Bloc test for a HIV diagnosis (Meyers et al.). African 
Americans were more likely than Caucasians to be offered HIV testing (OR = 1.06; 95% 
CI [1.01, 1.11]); African Americans were more likely to accept HIV testing (AOR = 1.08, 
95% CI [1.66, 2.04]) compared to Caucasians; and men with private insurance were less 
likely to accept HIV testing (OR = 0.82, 95% CI [0.70, 0.9], p < 0.0001) in contrast to 
men without insurance. Myers et al. found minimal HIV diagnosis in this high risk 
community population and speculated that the minimal HIV infections diagnosed may 
have occurred because of the window period where HIV antibodies are not yet detectable. 
Meyers et al. also noted that patients who presented with acute HIV disease symptoms 
were more likely to be misdiagnosed as influenza and to yield a false negative response 
on a rapid HIV test.   
Podhurst, Storm, and Dolgnos (2009) surveyed women from multi-geographical 
clinical sites in an effort to understand women’s perceptions of HIV opt-out-testing 
during pregnancy and to determine HIV knowledge. Women (N = 836) were from 
clinical sites in Puerto Rico (N = 73), Florida (N = 109), New York (N = 145), Illinois (N 
= 172), Michigan (N = 41), Mississippi (N = 102), New Jersey (N = 158), Wyoming (N = 
57), and not reported (N = 17).  Podhurst et al. found 82% of the women were aware of 
their HIV status; 75% reported negative, 7.0% positive, 13% unaware, and 5% did not 
report a HIV status. Podhurst et al. also reported that 755 (90%) of women agreed that 
HIV testing should be a routine part of prenatal care and 772 (91%) were comfortable 
with HIV testing during pregnancy. 
Podhurst et al. (2009) also administered a survey to 853 women regarding HIV 
transmission and reported correct and incorrect responses: (a) “Women can get HIV from 
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public toilet (p. 333).” [787 (92%) correct, 68 (8%) incorrect response] (b) “Women can 
give HIV to their babies (p. 333).” [694 (81.4%) correct, 158 (18.6%) incorrect response] 
(c) “Women can give their babies HIV during delivery (p. 333).” [551(64.6%) correct, 
302 (35.4%) incorrect response] (d) “Women can give their babies HIV through breast 
feeding (p.333).” [534 (62.6%) correct, 319 (37.4%) incorrect response] (e) “There are 
medicines that can help keep newborn infants from getting HIV when the mother is HIV 
positive (p. 333).” [524 (61.4%) correct, 329 (38.6%) incorrect response]. The women 
who were never tested were three times more likely to have lower HIV knowledge (OR = 
3.05, 95% CI [1.39, 6.99] than the women who self-reported to be positive; African 
American women were more likely to have lower HIV knowledge (OR = 1.57, 95% CI 
[1.04, 2.37]) than Caucasian women; and Hispanic women were three times more likely 
to have lower HIV knowledge (OR = 3.34, 95% CI [2.2, 5.10]) than Caucasian women 
(Podhurst et al.).    
Adherence to CDC Opt-Out HIV Testing Guidelines 
Jain, Wyatt, Burke, Sepkowitz, and Beiger (2009) found low adherence to opt-out 
HIV testing among medical residents and reported that of the 426 medical residents, only 
152 (35.8%) provided routine HIV testing to all patients and 274 (64.2%) of the residents 
used HIV behavior risk assessment to determine if there was a need for HIV testing. The 
barriers in ordering HIV testing among the medical residents were identified as (a) 
discomfort approaching patients to offer HIV testing, (b) counseling on positive results, 
and (c) assessing sexual history and risk behaviors (Jain et al.).  Additional analysis 
showed the 35.8% of the residents who offered HIV testing used one of the three 
approaches: (a) 21.3% offered HIV testing routinely when providing an exam, (b) 18.9% 
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offered to all new clinic patients, and (c) 13.2% offered to all clinic patients (Jain et al.). 
Interestingly, the (n = 95, 40.9%)medical residents who went to school outside the U.S. 
ordered greater than 10 HIV tests in the past month compared to 196 U.S. medical 
residents who ordered greater than 10 HIV tests in the past month (Jain et al.). Overall, 
medical residents 138 (32.4%) claimed to not be aware of the CDC 2006 HIV testing 
guidelines (n = 59, 29.9%; Jain et al.).  
Jain et al. found six variables that had significant association with medical 
residents ordering 10 or fewer HIV tests compared to medical residents that ordered 10 or 
more HIV tests. Provided are the adjusted odds ratio (AOR) that illustrate the HIV 
ordering practices as reported by medical residents:  
1. not comfortable with HIV pre-test counseling were less likely to order 
HIV testing compared to medical residents who were comfortable with 
HIV pre-test counseling (AOR 7.0, 95% CI [1.6, 41.7]).  
2. who did not provide risk based HIV testing were less likely to order HIV 
testing compared to medical residents who did provide HIV testing based 
on risk assessment (AOR 4.5; 95% CI [2.5, 8.2]). 
3. who reported never or occasionally obtaining sexual histories from 
patients were less likely to order HIV testing compared to medical 
residents who did obtain sexual histories (AOR 3.9, 95% CI [2.2, 7.2]). 
4. who reported never/occasionally referring patients to another medical 
doctor for HIV testing were less likely to perform HIV testing compared 
to medical residents who did refer patients to another medical doctor for 
HIV testing (AOR 2.8, 95% CI [1.4, 4.9]). 
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5. who reported being dissuaded by pre-counseling to order more tests were 
less likely to order a HIV test compared medical residents who were not 
dissuaded by pre-counseling to order more tests (AOR 2.6, 95% CI [1.4, 
4.9]). 
6. who never reported a HIV negative result to a patient were less likely to 
order a HIV test compared to medical residents who had reported HIV 
negative result to a patient (AOR 2.2, 95% CI [1.3, 3.8]). 
HIV Testing Patterns of African American Women 
Medina (2009) explored HIV testing and retesting trends among 56 women. The 
study participants included 32 (58%) African American women and 24 (42%) Latina 
women. The themes identified for HIV testing were the desire to know one’s status (N = 
16; 28.5%), apprehension regarding personal drug use (N = 8; 14.6%), apprehension 
about risk behavior (N = 6; 10.7%), and fear ([N = 6; 10.7%]; Medina). The primary 
reason for the women to be HIV retested was to monitor HIV status (N = 26; 46.4%); the 
women reported having male partners who had multiple sex partners (Medina).  There 
were 21 (37.5%) women who provided no response and 13 (23.2%) women who reported 
HIV retesting was related to apprehension about their participation in these risky 
behaviors: (a) IV drug use, (b) unprotected sex, (c) having more than one sexual partner, 
and (d) sexual partner’s risky sex behaviors or drug use (Medina, 2009). These women 
volunteered to be a part of the study, which may have an influenced the large number of 
women who chose HIV testing and retesting. 
A cross-sectional study of 571 African American women of low income from 
Missouri who completed a self-administered survey found 52.6% of rural women and 
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57.4% of the non-rural women reported having been HIV tested (Crosby,Yarber, 
Diclimente, Wingood, & Meynerson, 2002). The non-rural women were less likely to 
participate in HIV or STD prevention methods, utilize condoms, and more likely to trust 
that their partner was HIV negative if tested or not (Crosby et al.). 
Summary 
This review of the literature found that African American women with a history 
of drug use are at risk for HIV infection and STDs. Drug use may alter thinking 
processes, promote impulsivity, and distort judgment (NIDA, 2012). Thus African 
American women with drug use behaviors combined with risky sexual behaviors and 
trading sex behaviors all contribute to an increased risk for HIV infection.  This review 
also found that understanding the attitudes of African American woman about HIV/AIDS 
and risky sexual behavior are important factor in preventing HIV transmission. 
Additionally, African American women’s knowledge about actions to prevent HIV and 
STDs are also an important factor in preventing HIV transmission.  
Early HIV testing is important for African American women with a known risk(s) 
of becoming HIV infected in order to be aware of their HIV status. Early HIV treatment 
with antiretroviral agents during early phase of HIV infection reduces the transmission of 
HIV by suppressing viral replication and progression of disease (HHS, 2013). Even more 
important, studies have shown women who are aware of their HIV positive status are 
more likely to change behaviors (unprotected sex, sharing needles) to prevent the spread 
of HIV (CDC, 2013f; Marks, Crepaz , Senterfitt,  & Janssen, 2005).  Early detection of 
HIV is imperative so the woman can be linked to a healthcare team resulting in early 
treatment with antiretroviral agents, counseling, and continuous follow up care (HHS, 
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2013). Moreover, early detection with treatment coupled with awareness of behavioral 
changes can prevent the spread of HIV to other persons (CDC, 2013f; HHS, 2013).  
For nurses, the gap in knowledge is determining factors that can guide African 
American women with HIV/STD risk factors to seek HIV testing. Nurses are in a unique 
position to counsel and guide African American women with a history of drug use to 
reduce their risk of HIV or STDs and to seek HIV testing. Thus, it is important to study 
African American women’s attitudes about HIV/AIDS and risky sexual behavior as well 
as knowledge about actions to prevent HIV or STDs in order to learn factors that 
influence African American women’s decision to seek or to avoid HIV testing. This study 
seeks to add to the body of knowledge of public health nurses to improve nurses ability to 
educate women at risk for HIV/STDs and the need for HIV testing and early detection of 
HIV.  
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Chapter III 
 
Introduction 
The purposes of this investigation were to examine an existing data set from a 
sample of African American women with a history of drug use and who are at high risk 
to acquire or transmit HIV and/or STDs to determine the women’s knowledge and 
attitudes about risky sexual behaviors, factors influencing a decision to have HIV testing, 
and the influence of sex trading on the decision to have HIV testing.   
Research Questions 
This study was designed to answer the following research questions: 
1. What knowledge do women have about actions before and after sex to prevent 
acquiring HIV or STDs? 
2. What are women’s attitudes about risky sexual behaviors? 
3. Will women’s knowledge about risky sexual behavior influence her decision to 
have HIV testing? 
4. Will women’s attitudes about risky sexual behavior influence her decision to have              
HIV testing? 
5. Are there interactions between women’s knowledge to prevent HIV, attitudes 
about risky sexual behavior, and the women’s decision to have HIV testing? 
6. Is there difference in women who engage in sex-trading versus women who do 
not engage in sex-trading and their decision to have HIV testing? 
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Methodology 
Research Design 
 The study design was a secondary data analysis of existing data collected in a 
study conducted at a large Midwestern University School of Medicine that investigated 
the efficacy of a female oriented model delivered at discrete intervals to decrease drug 
use and sexual risks behaviors (Cottler, 2006). This original study was funded by 
National Institute of Drug Administration (NIDA).  The intervention study, focused on  
women, aimed to reduce drug use and HIV/ sexual transmitted infection (STD) risk 
behaviors (Cottler, 2006). Participants in the study were randomly assigned to one of the 
three peer dispensed interventions: (a) a modified NIDA cooperative agreement standard 
intervention, (b) standard intervention plus well woman exam, and (c) standard 
intervention, plus well woman exam, plus four educational sessions. The investigators 
examined the degree of variance and effects of reducing high risk drug and sexual 
behaviors from the differentiated interventions (Cottler).  
There were multiple advantages to performing secondary analysis of existing 
data. Boslaugh (2007) noted the following advantages of secondary analysis:  
1. promotes the generation of new hypothesis extending the intended purpose 
2. frees the researcher from expending direct and indirect cost on the data 
collection phase, such as time and money 
3. de-identifies so data is free of any personal identifiers 
4. allows the researcher more time for analyzing data and testing hypotheses 
There were also multiple disadvantages to secondary analysis of existing data. 
Boslaugh (2007) noted that the disadvantages include no control over original data 
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collection methods, variables may be defined or categorized differently, operational 
definitions may have been characterized with broader or narrower descriptions than 
desired, an inability to collect additional information from the original sample, or 
inability to verify the data cleaning process.  
Sample and Setting 
The setting for the original study was a large city in the Midwest. In order to 
recruit the women, community health outreach workers provided a potential participant 
with an abbreviated synopsis of the study and eligibility to participate in the study. The 
inclusion criteria for participants of the study were: (a) female; (b) >18 years of age; (c) 
self-reported to be sexually active within the last 4 months; (d) recent use of 
amphetamines, cocaine or heroin; (e) have not attended substance abuse treatment 
program within the last 30 days; and (e) self-reported to be residing in the large 
Midwestern city. Exclusion criteria were: (a) under age 18, (b) male or transgender, (c) 
not sexually active with the past four months, (d) no recent drug use of amphetamines, 
cocaine or heroin, or (e) resides outside the large Midwestern city (Cottler, 2006).  
Vaddiparti et al. (2006) recommended participant recruitment using community 
advertisement in neighborhood newspapers and the posting flyers in geographical venues 
that were observable by the target population.  Thus, women were also recruited for the 
initial study at nightclubs, bars, hair and beauty salons, bus stations, and laundromats.  
Additionally, women were referred by caseworkers from the Midwestern city Female 
Drug Courts and social services agencies.  Potential participants were also referred by 
friends. The recruited participants were interviewed and surveyed at Midwestern health 
department. 
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There were 761 African American women recruited in the original study.  For this 
secondary data analysis only African American women with a drug history were included 
(Cottler, 2006). Of the original sample, 99.5% (N = 751) of the women were included in 
this study.  The following data were available from the original study: (a) frequency of 
HIV testing among the women, (b) knowledge of actions before after sex to prevent an 
STD and HIV, (c) attitudes towards risky sexual and attitudes about sex, and (d) 
frequency of trading sex for drugs, money, food, place to stay or clothes (Cottler, 2006). 
Demographic variables available included age and income level.  
Operational Definitions 
 Operational definitions for this investigation were derived from the inclusion 
criteria for the subjects and the Washington University Risk Behavior Assessment of 
Women ([WU-RBA-W]; see Appendix A) instrument categories: HIV testing; risky 
sexual behaviors: sexual activity; sex trade: sex for money/drugs/food; knowledge: sexual 
activity before and after sex; attitudes: HIV/AIDS (Cottler, 2006). 
African American Women with a History of Drug Use 
 African American women with a positive urine drug test for cocaine, 
amphetamines, or opiates; and/or physical presence of track marks from recent 
intravenous drug use were considered to have a history of drug use. 
HIV Testing 
HIV testing was defined as the score on the WU-RBA-W for number of times 
tested, responses to 14 yes/no questions, and one open ended question related to HIV 
testing (Cottler, 2006; see Appendix A). 
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Risky Sexual Behaviors: Sexual Activity 
Risky sexual behaviors-sexual activity were defined as the score on the WU-
RBA-W in response to having had sex in the past four months and five open ended 
questions related to number of times engaging in risky sexual behavior (see Appendix A).  
Sex Trade: Sex for Drugs/Money/Food/Place to Stay/Clothes 
Sex trade-sex for money/drugs/food /place to stay, clothes were defined as the 
score on WU-RBA-W in response to four open ended questions asking number of times 
in the past four months subjects traded sex for drugs alcohol, money, food, a place to stay 
or clothes; 24 yes/no questions about trading sex for drugs alcohol, money, food, a place 
to stay or clothes with an answer of yes defined as a sex trade; and one open ended 
question specifying other drugs used (Cottler, 2006; see Appendix A).  
Knowledge: Sexual Activity Before and After Sex 
 Knowledge-sexual activity before and after sex were defined as the score on the  
WU-RBA-W in response to the 17 yes/no questions related to behaviors performed 
before and after sex keep from getting STDs or HIV (Cottler, 2006; see Appendix A). 
Attitudes about HIV/AIDS and Risky Sexual Behavior 
 Attitudes were defined as the score on the WU-RBA-W in response to three 
statements about subjects attitudes towards sex (agree, neutral, disagree) sexual, drug use, 
drinking behaviors that need changing; one question related to perception of the most 
risky behavior in terms of causing HIV/AIDS (not using condoms, sharing needles, using 
alcohol or drugs before or during sex): and five questions (agree, neutral, disagree) 
related to perception of if they get the HIV virus (Cottler, 2006; see Appendix A).  
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Instrumentation 
The Washington University Risk Behavior Assessment of Women (WU-RBA-W) 
was modeled after the 1991 Risk Behavior Assessment (RBA) developed by the National 
Institute of Drug Abuse (NIDA) jointly with the grantees of AIDS Cooperative 
Agreement (Needle et al., 1995; Vaddiparti et al., 2006; ee Appendix A). The WU-RBA 
–W is a self-report survey that  includes 14 yes/no questions about HIV testing, one 
yes/no question with five open ended questions with responses scored for risky sexual 
behaviors, (sexual activity); two open ended questions with a response score, and 13 
yes/no questions and two open ended questions with a  response score related to sex trade 
(sex for money/drugs/food/place to stay/clothes); 17 yes/no questions related to  
knowledge (activities before and after sex to prevent HIV and STDs); and eight 
statements with categorical responses of agree/neutral/disagree, one statement with scale 
of the most risky behavior causing HIV/AIDS, and three yes/no questions related to 
attitudes ([HIV/AIDS], Cottler, 2006; see Appendix A). There is no psychometrics on the 
WU-RBA-W. The NIDA Cooperative Agreement RBA yields a range of reliability from 
moderate to strong association (r = .66, SEM = 3.29 to r = .83, SEM = 3.25; Needles et 
al. 1995). The WU-RBA-W tool is an assessment tool that provides incidence data at 
nominal and interval levels of measurement (Cottler, 2006). The WU-RBA-W was a 
baseline assessment administered to the women by a research assistant with responses 
recorded electronically on the computer prior to HIV education (Cotter, 2006). 
The WU-RBA-W has items inquiring of (a) the number of times the participant 
has procured HIV testing, (b) if test results were received with the last HIV test, and (c) 
reasons for not getting HIV tested. The items have good face validity. Test–retest 
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reliability on the continuous RBA item, “How many times, if any, have you had a test for 
HIV virus?” reveals good reliability, Pearson correlation (r)  =  .82 (Fisher, Reynolds, 
Jaffe, & Johnson, 2007). The test-retest reliability on the dichotomous variable, “Did you 
get your test results that last time?” reveals slight to fair agreement with Cohen’s kappa 
()  =  .22 with 95% confidence interval [.118, .332] (Fisher et al., 2007). 
Informed Consent 
Approval of the original secondary data analysis was obtained from the 
Washington University Human Studies Committee while a pre-doctoral student at 
Washington University School of Medicine (TL1 TR000449). The data has been de-
identified so that there are no personal identifiers and subjects are completely 
anonymous. Approval for this secondary analysis of this de-identified data set was 
obtained from the University of Missouri-St. Louis Institutional Review Board. This de-
identified data is stored on pass word protected computer at University Florida that 
requires remote access and computer password entry to University Florida computer then 
another remote access with password to statistical lab and data storage (Cottler, 2006). A 
code book had been created to document changes in codes, variables with numerical 
codes present, dummy variables that are created, and tests that were performed.  
Data Collection 
After signing informed consent in the original study, the WU-RBA-W survey was 
administered by research assistant, during participant interview, (Cottler, 2006). All 
participants received modest cash reward for their time (Cottler). The original data came 
from a dataset that was compiled from NIDA grant, R01DA11622A,  funded research 
(Cottler, 2006). 
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Data Analysis 
Statistical analysis was done using SPSS 21 statistical software. Descriptive 
statistics were used to characterize the sample with selected socio-demographic variables 
of age and income level. Descriptive statistics provided the mean number of HIV tests 
and range of the number of HIV test done among participants, frequency of the 
participants’ responses of the behaviors employed before and after sex to prevent 
HIV/STD are identified as knowledge variables, and the frequency of self-reported 
beliefs of HIV risk among the participants were identified as attitude variables.  
Binary logistic regression was performed using the variable predictors from the 
data set. These variables included demographic variables, number of times participants 
HIV tested, sex trade (yes, no), behaviors considered most risky (no condoms, sharing 
needles, or using alcohol or drugs before sex), sexual practices (used or not used) to 
prevent HIV/STD, HIV knowledge, and HIV attitudes. 
The advantage of using logistic regression was the ability to analyze discrete, 
continuous, and dichotomous variables. Binary logistic regression has no assumptions to 
be met about predictor variables being normally distributed; this provided the flexibility 
of using such a homogenous sample. Binary logistic regression is flexible in producing 
non-linear models (Mertler & Vannatta, 2005).  
The disadvantage of binary logistic regression was it could lead to high 
correlations among predictor values and a condition of multicollinearity (Mertler & 
Vannatta, 2005). Multicollinearity can make it difficult for the researcher to discern, 
which independent variable is influencing the dependent variable (Mertler & Vannatta, 
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2005).  Binary logistic regression is sensitive to outliers and can create poor fit for the 
model (Mertler & Vannatta, 2005).  
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Chapter IV 
 
Results 
This chapter presents the characteristics of the sample. Results for research 
questions one through six are presented. 
Sample Profile  
The study sample was derived from a preexisting data base of 761 African 
American women with a history of drug use. Ten cases were missing age data and were 
removed from the sample.  The resulting sample size was 751 African American women 
with a history of drug use. Other missing data will be reported as missing values for 
analysis. Demographic data selected for this investigation include income level, age, and 
if the women had a HIV test. This sample of African American women ages ranged 
from18 to 65 years. Ages were transformed and recoded into stratified age groups to 
mirror the stratification used by the CDC for collecting HIV data and categorical income 
levels were derived from the data set.  The majority of women (86.0%) were aged 18 to 
44 years, over half (50.6%) were aged 35 to 44 years, and the majority (84.6%) had an 
income below $11,000 (see Table 1).  
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Table 1 
 
Demographic Characteristics of Women by Age and Income Level 
  
Characteristic n % 
Age category   
  18 - 24 90 12.0 
  25 - 34 176 23.4 
  35 - 44 380 50.6 
  45 - 54 91 12.1 
  55 - 64 13 1.7 
  65 - 65+ 1 .1 
Total 751 100.0 
Income previous 12 months   
  $0 - $3,999  363 48.4 
  $4,000 - $6,999 170 22.7 
  $7,000 - $10,999 101 13.5 
  $11,000 - $14,999 46 6.1 
  $15,000 - $18,999 25 3.3 
  $19,000 - $24,999 19 2.5 
  $25,000 - $34,999 12 1.6 
  $35,000 - $44,999 6 .8 
  $45,000 - $64,999 4 .5 
  $65,000- $100,000 3 .4 
  Missing 1 .1 
Total 750 99.9 
 
The majority, 673 (89.7%) of African American women responded yes, they had 
been HIV tested, only 77 (10.3%) responded no to having been HIV tested, and one 
(.1%) did not respond to the question. Cross-tabulation was used to determine the number 
of HIV tests among the age categories of participants (see Table 2) and the number of 
times tested (see Table 3). The largest number of women (380) reported yes or no to HIV 
testing were aged 35 to 44 years. Women aged 25 to 34 years (93.1%) and aged 35 to 44 
years (91.1%) had a greater percentage of HIV testing than other cohorts of women. The 
number of times tested ranged from one time to greater than ten times. The majority of 
times the women reported testing were one to two times (39.3%) and three to four times 
(26.5%).  Of the women who reported HIV testing, 379 (50.4 %) women had been HIV 
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tested more than two times and 295 (39.3%) women had been HIV tested one to two 
times (see Table 3). 
Table 2 
Number and percent of HIV test done by Age Category (n = 750) 
 No HIV test Yes HIV test 
Age category n % n % 
18 - 24 14  15.6 76  84.4 
25 - 34 12  6.9 163 93.1 
35 - 44 34 8.9 346 91.1 
45 - 54 15 16.5 76 83.5 
55 - 64 2 15.4 11 84.6 
65 - 65+ 0 0.0 1 100.0 
Total 77 10.3 673 89.7  
 
Table 3 
 
Number of times tested and percent of HIV Tests by Age Category (n = 751)  
Number of HIV Testes 
Age 
category 
0  
n (%) 
1- 2 
n (%) 
3- 4  
n (%) 
5 - 6  
n (%) 
7 -8 n 
(%) 
9-10  
n (%) 
> 10 
n (%) 
        
Total 
18 - 24 14 
(15.6) 
42 
(46.7) 
19 
(21.1) 
7  
(7.8) 
1 
(1.1) 
2 
(2.2) 
5 
(5.6) 
90 
 
25 - 34 12 
(6.8) 
62 
(35.2) 
54 
(30.7) 
23 
(13.1) 
5 
(2.8) 
6 
(3.4) 
14 
(8.0) 
176 
 
35 - 44 34 
(8.9) 
150 
(39.5) 
103 
(27.1) 
47 
(12.4) 
12 
(3.2) 
18 
(4.7) 
16 
(4.2) 
380 
 
45 - 54 15 
(16.5) 
34 
(37.4) 
19 
(20.9) 
14 
(15.4) 
3 
(3.3) 
4 
(4.4) 
2 
(2.2) 
91 
 
55 - 64 2  
(15.4) 
6  
(46.2) 
4 
(30.8) 
0 
(0.0) 
1 
(7.7) 
0 
(0.0) 
0 
(0.0) 
13 
 
65 - 65+ 0 
(0.0) 
1 
(100.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
1 
Total 
HIV tests 
77 
(10.3) 
295 
(39.3) 
199 
(26.5) 
91 
(12.1) 
22 
(2.9) 
30 
(4.0) 
37 
(4.9) 
751 
 
Of the 673 women who had HIV testing, 555 (82.2%) received results and 120 
(17.8%) did not receive results. Women were asked the reason for not having a HIV test. 
Reasons reported by participants for not being HIV tested: (a) 206 (27.5%) were afraid to 
know HIV status (b) 156 (20.8%) believed they were not be at risk, (c) 147 (19.6%) 
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feared others would find out HIV status is positive, and (d) 75 (10.0%) feared of 
contracting AIDS from the test.   
Research Question Results  
Research question 1. What knowledge do women have about actions before and 
after sex to prevent acquiring HIV or STDs? There are seventeen knowledge items used 
from the Washington University Risk Behavior Assessment of Women (WU-RBA-W) 
that have dichotomous recorded responses of no or yes about the women’s activity 
performed to prevent contracting a STD or HIV/AIDS. Descriptive analysis was 
performed.  Activities include: (a) Cleanse before sex (soap); (b) cleanse after sex (soap, 
douche, alcohol, bleach/peroxide); (c) cleanse partner before sex (soap); (d) cleanse 
partner after sex (alcohol, bleach/peroxide); (e) sex partner history (ask partner sex 
history, ask if HIV positive); (f) substitution for vaginal sex (oral sex, anal sex); and other 
actions (partner ejaculation, urination, antibiotics, healthy looking partner, ear wax). An 
activity, inserting ear wax in the woman’s vagina, is believed that an STD can be 
identified if vaginal burning is the resultant of this activity. Only 90 (12%) of the women 
did not respond to any of the questions about their activity performed to prevent 
contracting a STD or HIV/AIDS while 603 to 662 of the women responded to the 
majority of the questions.   
There were 322 (48.7%) women who responded yes and 339 (51.3%) no to 
washing genitals with soap before sex (see table 4). Over half of the women aged 25 to 
34 and 35 to 44 reported washing genitals with soap before sex. With the exception of 
women aged 65 or more, all age categories reported washing genitals with soap after sex 
about 50% to 60% of the time; only 18 (25.7%) of women aged 18 to 24 douched after 
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sex while women aged 25 to 64 years reported douching nearly 50 percent of the time; 
few women reported cleansing with alcohol or bleach after having sex in all age 
categories (see Table 4).  
Table 4.  
Cleansing Prior to and After Sex to Prevent STD or HIV/AIDS by Age Category  
 Cleanse prior Cleanse after 
Age 
category 
yes/no 
 
Soap 
n (%) 
 
Soap 
n (%) 
 
Douche 
n (%) 
 
Alcohol 
n (%) 
 
Bleach 
n (%) 
18-24 70 70 70 70 70 
  Yes 
   No 
29 (41.4) 
41 (58.6) 
38 (54.3) 
32 (45.7) 
18 (25.7) 
52 (74.3) 
5 (7.1) 
65 (92.9) 
1(1.4) 
69 (98.6) 
25-34 145 145 145 145 145 
  Yes 
   No 
73 (50.3) 
72 (49.7) 
85 (58.6) 
60 (41.4) 
67 (46.2) 
78 (53.8) 
16 (11.0) 
129 (89.0) 
8 (5.5) 
137 (94.5) 
35-44 341 341 341 341 341 
  Yes 
  No 
171  (50.1) 
170 (49.9) 
229 (67.2) 
112 (32.8) 
164 (48.1) 
177 (51.9) 
52 (15.2) 
289 (84.8) 
31 (9.1) 
310 (90.9) 
45-54 91 91 91 91 91 
  Yes 
  No 
43 (47.3) 
48 (52.7) 
56 (61.5) 
35 (38.5) 
44 (48.4) 
47 (51.6) 
12 (13.2) 
79 (86.8) 
7 (7.7) 
84 (92.3) 
55-64 13 13 13 13 13 
  Yes 
   No 
6 (46.2) 
7 (53.8) 
8 (61.5) 
5 (38.5) 
6 (46.2) 
7 (53.8) 
3 (23.1) 
10 (76.9) 
4 (30.8) 
9 (69.2) 
65-65+ 1 1 1 1 1  
  Yes 
  No 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
Total 661 661 661 661 661 
  Yes 
  No 
322 (48.7) 
339 (51.3) 
416 (62.9) 
245 (37.1) 
299 (45.2) 
362 (54.8) 
88 (13.3) 
573 (86.7) 
51 (7.7) 
610 (92.3) 
 
Only 277 (41.9%) of the women asked their partner about their sex history; 
however, the majority of women 394 (59.6%) asked their partner if they were HIV 
positive (see Table 5).  Over half of the younger women aged 18 to 24 years asked their 
partner’s sex history while over half of women aged 18 to 65 years asked their partner if 
they were HIV positive (see Table 5).  Few women reported substituting oral or anal sex 
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for vaginal sex.  The most frequent yes response for substituting vaginal sex with oral sex 
to prevent STD or HIV/AIDS were women aged 25 to 34 years 24 (16.6%) and aged 35 
to 44 years 56 (16.4%); only 22 (3.3%) of the responded yes to substituting vaginal sex 
with anal sex (see Table 5). 
Table 5  
Sex Partner History and Substitute for Vaginal Sex to Prevent STD or HIV/AIDS by Age 
Category  
 Sex partner history Substitute for vaginal sex 
Age 
category 
Ask partner 
sex history 
Ask partner if 
HIV positive 
 
Oral sex 
 
Anal sex 
yes/no n (%) n (%) n (%) n (%) 
18-24 70 70 70 70 
  Yes 
   No 
36 (51.4) 
34 (48.6) 
47 (67.1) 
23 (32.9) 
10 (14.3) 
60 (85.7) 
0 (0.0) 
70 (100.0) 
25-34 145 145 145 145 
  Yes 
   No 
64 (44.1) 
81 (55.9) 
86 (59.3) 
59 (40.7) 
24 (16.6) 
121 (83.4) 
4 (2.8) 
141 (97.2) 
35-44 341 341 341 341 
  Yes 
  No 
137 (40.2) 
204 (59.8) 
200 (58.7) 
141 (41.3) 
56 (16.4) 
285 (83.6) 
15 (4.4) 
326 (95.6) 
45-54 91 91 91 91 
  Yes 
  No 
35 (38.5) 
56 (61.5) 
52 (57.1) 
39 (42.9) 
11 (12.1) 
80 (87.9) 
3 (3.3) 
88 (96.7) 
55-64 13 13 13 13 
  Yes 
  No 
5 (38.5) 
8 (61.5) 
9 (69.2) 
4 (30.8) 
0 (0.0) 
13 (100.0) 
0 (0.0) 
13 (100.0) 
65-65+ 1 1 1 1 
  Yes 
  No 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
Total 661 661 661 661 
  Yes 
  No 
277 (41.9) 
388 (58.1) 
394 (59.6) 
267 (40.4) 
101 (15.3) 
560 (84.7) 
22 (3.3) 
639 (96.7) 
 
Women were asked to report other actions to prevent STD or HIV/AIDS. These 
include: (a) not allowing sex partner to ejaculate in the vagina, (b) urination after sex, (c) 
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taking antibiotics after having sex, (d) having sex with only healthy looking partners, and 
(e) using ear wax to determine if STD is present. 
Partner ejaculation. Of the 661 participants, 397 (60.1%) women responded yes 
to not allowing their partner to ejaculate in the vagina and 264 (39.9%) responded no. 
The most frequent yes responses were women aged 25 to 34 years 60 (41.4%) and 35 to 
44 years 139 ([40.8%], see Table 6). 
Urination after sex. Of the 661 participants, 335 (50.7%) women responded yes 
and 326 (49.3%) responded no to urination after sex. Women aged 35 to 44 years 195 
(57.2%) responded most often to urinating after sex to prevent STD or HIV/AIDS (see 
Table 6). 
Taking antibiotics after sex.  Of the 661 participants, 76 (11.5%) women 
responded yes and 585 (88.5%) responded no to taking antibiotics after sex.  Yes 
responses greater than 10% for taking antibiotic after sex to prevent STD or HIV/AIDS 
were women aged 35 to 44 years 50 (14.7) and aged 45 to 54 years 13 ([14.3%], see 
Table 6). 
Having sex with only healthy looking partners. Of the 661 participants, 310 
(46.9%) women responded yes and 351 (53.1%) women responded no to having sex only 
with healthy partners. The cohorts with approximately half and slightly greater than half 
that engaged in sex only with healthy looking partners to prevent STD or HIV/AIDS 
were women aged 35 to 44 years 170 (49.9%), 45 to 54 years 46 (50.5%), and 55 to 64 
years 7 ([53.8%], see Table 6). 
Using ear wax used to determine if an STD is present. Of the 603 participants, 33 
(5.5%) women responded yes and 570 (94.5%) responded no to using ear wax to 
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determine if an STD was present in their partner. Women aged 25 to 34 years provided 
almost one third of the yes responses 13 (10.2%) to using ear wax to prevent STD or 
HIV/AIDS (see Table 6).  
Table 6  
Other Actions to prevent STD or HIV/AIDS by Age Category  
 Other actions to prevent STD or HIV/AIDS 
Age 
category 
Partner 
ejaculation 
 
Urination 
 
Antibiotics 
Healthy 
looking partner 
 
Ear wax 
yes/no n (%) n (%) n (%) n (%) n (%) 
18-24 70  70 70 70 63 
  Yes 
   No 
27 (38.6) 
43 (61.4) 
28 (40.0) 
42 (60.0) 
3 (4.3) 
67 (95.7) 
25 (35.7) 
45 (64.3) 
2 (3.2) 
61 (96.8) 
25-34 145 145 145 145 127 
  Yes 
   No 
60 (41.4) 
85 (58.6) 
65 (44.8) 
80 (55.2) 
10 (6.9) 
135 (93.1) 
61 (42.1) 
84 (57.9) 
13 (10.2) 
114(89.8) 
35-44 341 341 341 341 308 
  Yes 
  No 
139 (40.8) 
202 (59.2) 
195 (57.2) 
146 (42.8) 
50 (14.7) 
291 (85.3) 
170 (49.9) 
171 (50.1) 
16 (5.2) 
292 (94.8) 
45-54 91 91 91 91 91 
  Yes 
  No 
35 (38.5) 
56 (61.5) 
42 (46.2) 
49 (53.8) 
13 (14.3) 
78 (85.7) 
46 (50.5) 
45 (49.5) 
2 (2.2) 
89(97.8) 
55-64 13 13 13 13 13 
  Yes 
  No 
3 (23.1) 
10 (76.9) 
5 (38.5) 
8 (61.5) 
0 (0.0) 
13 (100.0) 
7 (53.8) 
6 (46.2) 
0 (0.0) 
13 (100.0) 
65-65+ 1 1 1 1 1 
  Yes 
  No 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
1 (100.0) 
0 (0.0) 
0 (0.0) 
1 (100.0) 
Total 661 661 661 661 603 
  Yes 
  No 
397 (60.1) 
264 (39.9) 
335 (50.7) 
326 (49.3) 
76 (11.5) 
585 (88.5) 
310 (46.9) 
351 (53.1) 
33 (5.5) 
570 (94.5) 
 
Research question 2. What are women’s attitudes about HIV/AIDS and risky 
sexual behaviors? The WU-RBA-W has 11 questions with categorical responses asking 
women’s attitudes about HIV/AIDs and risky sexual behaviors.  Descriptive statistics 
were used to analyze the responses of 751 African American women.  
 Green, Lisa, UMSL 75 
 
When asked to respond (agree, disagree, neutral) about having risky sex behaviors 
that need changing, 255 (34.0%) women agreed, 464 (61.8%) disagreed, and 32 (4.3%) 
were neutral. The women were also asked about having risky drug behaviors and risky 
drinking behaviors that need changing: (a) risky drug behaviors 355 (47.3%) agreed, 372 
(49.5%) disagreed and 24 (3.2%) were neutral, and (b) risky drinking behaviors 288 
(38.3%) agreed, 441 (58.7%) disagreed, and 22 (2.9%) were neutral.  
Women were asked which behavior is the most risky for causing HIV/AIDS (a) 
not using condoms, (b) sharing needles, or (c) using alcohol or drugs before sex. Almost 
half 374 (49.8%) of the women responded sharing needles was the most risky, 344 
(45.8%) responded not using condoms, and only 33 (4.4%) replied using alcohol or drugs 
before sex. 
When women were asked if they thought a steady partner had ever cheated on 
them or had they ever cheated on one of their steady partners: (a) 508 (67.6%) responded 
yes, their steady partner had cheated on them and 243 (32.4%) responded no; (b) 462 
(61.5%) replied yes, they had cheated on one of their steady partners and 289 (38.5%) 
responded no.  When asked if having one sex partner is more safe than having two or 
more sex partners, 639 (85.1%) of women answered yes, and 112 (14.9%) responded no.  
Women were asked to respond to five statements with agree, disagree, neutral: (a) 
I am in control of whether or not I get the HIV virus; 476 (63.4%) agreed, 240 (32.0%) 
disagreed, and 35 (4.7%) were neutral. (b) If I get the HIV virus, it is my destiny - it is 
meant to be; 189 (25.2%) agreed, 531 (70.8%) disagreed, and 30 (4.0%) were neutral. (c) 
Other people play a big part in whether I get the HIV virus; 375 (49.9%) agreed, 354 
(47.1 %) disagreed, and 22 (2.9%) were neutral. (d) Whether or not I get the HIV virus 
 Green, Lisa, UMSL 76 
 
depends on my sex partner; 438 (58.3%) agreed, 286 (38.1%) disagreed, and 27 (3.6%) 
were neutral. (e) My own behaviors determine whether I get the HIV virus; 631 (84.0%) 
agreed, 106 (14.1%) disagreed, and 14 (1.9%) were neutral.  
Research question 3. Will women’s knowledge about risky sexual behavior 
influence her decision to have HIV testing? Independent t-tests were performed on the 
women’s responses to knowledge questions from the WU-RBA-W about actions prior 
and after sex to prevent STD or HIV/AIDS to determine if there were significant 
differences in the number of HIV tests. Of the 659 women who reported HIV testing and 
responded to the two knowledge questions (ask if partner is HIV positive and ask about 
partner’s sex history) the results were significant. Item analysis compared the number of 
times women reported HIV testing who asked if their partner was HIV positive and 
women who did not ask if their partner was HIV positive; and women who asked their 
partner’s sex history and women who did not ask their partner’s sex history.  
There was a significant difference in the number of HIV tests for women who 
asked their partner if they were HIV positive (M = 4.65, SD = 8.48) compared to women 
who did not ask their partner if they were HIV positive (M = 2.87, SD = 3.20); t (539) =  
-3.79, p = 0.00 (see Appendix B). There was also a significant difference between the 
number of times women were HIV tested who asked their partner about their sex history 
(M = 4.66, SD = 8.04) compared to women who did not ask their partner about their sex 
history (M = 3.40, SD = 5.93); t (480) = -2.21, p = .03 (see Appendix B).  
 Additional statistical analyses were performed. Results from the Hosmer and 
Lemeshow test showed women’s knowledge about risky sexual behavior had less 
deviation between the observed and expected outcomes of women who had HIV testing 
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revealing that a predictive ability was present using binary logistic regression analysis. In 
contrast, a greater deviation between the observed and expected outcomes of women who 
did not have HIV testing was noted, revealing less predictive ability using the binary 
logistic regression analysis. The binary logistic regression model demonstrated an 88.7% 
ability to predict HIV testing. According to the model summary, the model showed a 
variation of 10.0% of the women’s decision to be HIV tested was influenced by the 
women’s knowledge of risky sexual behaviors (Nagelkerke R2 = .100; see Appendix E). 
The knowledge items of risky sexual behavior that show significance with having HIV 
testing were (a) not let partner ejaculate in you to prevent HIV infection (p = .020), (b) 
took antibiotics to prevent HIV infection (p = .042), and (c) asked partner if HIV positive 
(p = .003).  When running Kendall’s Tau-b (Tau-b) correlation analysis on HIV testing 
and knowledge items about risky sexual behavior, a weak,  positive relationship was 
present for having HIV testing and answering  yes to the following items: (a) not let 
partner ejaculate in you to prevent HIV infection (Tau-b = .097, p = .013), (b) took 
antibiotics to prevent HIV infection (Tau-b = .094, p = .016), and (c) asked partner if 
HIV positive (Tau-b = .117, p = .003).  The Wald criterion revealed that only one 
knowledge item, asked partner if HIV positive, was a significant predictor for HIV 
testing (Wald = 8.490, df = 1, p = .004; see Appendix E).  The model showed that 
women who asked their partner if they were HIV positive were 1.26 times (26%) more 
likely to decide to be HIV tested (Exp[B]) = 1.265, 95% CI [1.024, 4.177]; see Appendix 
E).  
Research question 4. Will women’s attitudes about risky sexual behavior 
influence her decision to have HIV testing? An independent sample t-test was conducted 
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to compare the number of times the women were HIV tested who reported yes to the 
risky sexual behavior of ever cheating on one of their steady sex partners and women 
who reported no to ever cheating on one of their steady sex partners. The sample size 
ranged from 712 to 749 because neutral responses by the woman were excluded from the 
analysis. There was a significant difference in the number HIV tests for women who 
reported cheating on one of their steady sex partners (M = 4.25, SD = 7.49) and the 
women who did not cheat on one of their steady sex partners (M = 3.28, SD = 4.67);  
t (747) = - 2.19, p = .03 (see Appendix C). There was also a significant difference for 
women who agreed that their own risky sexual behaviors determined whether they 
contract the HIV virus (M = 4.06, SD = 7.00) compared to the women who disagreed  
(M = 2.98, SD = 3.37); t (288) = 2.50, p = .01 (see Appendix C).  
Cramer’s V analysis was used to compare the number of HIV tests and risky 
sexual behaviors (not using condoms, sharing needles, or using alcohol before sex) that 
can result in contracting HIV/AIDS.  Using Cramer’s V, there was a significant weak 
relationship between the number of HIV tests and the risky sexual behaviors (not using 
condoms, sharing needles, or using alcohol before sex) causing HIV/AIDS (V = .145, p < 
.001). 
Of the 200 women who reported having three to four HIV tests, 118 (59.0%) 
believed sharing needles was the riskiest sexual behavior for causing HIV/AIDS. In 
contrast the 91 women who reported having five to six HIB tests; 50 (54.9%) women 
believed not using condoms was the riskiest sexual behavior to cause HIV/AIDS.  A 
significant weak relationship was found between the number HIV tests and women who 
had responded yes to cheating on their sex partner (Cramer’s V = .133, p < .038).  
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Additional statistical analyses were performed. Results from the Hosmer and 
Lemeshow test showed women’s attitudes about risky sexual behavior had less deviation 
present among observed and expected outcomes of the women who were HIV tested 
revealing a predictive ability is present with binary logistic regression analysis. In 
contrast, a greater deviation was noted in observed and expected outcomes of women 
who did not have HIV testing revealing the logistic regression model had less predictive 
ability. The model demonstrated an 89.7% ability to predict HIV testing. According to 
the model summary, the model showed a small variation of 4.3% of the women’s 
decision to be HIV tested was influenced by the women’s attitudes about risky sexual 
behavior (Nagelkerke R
2
 = .043; see Appendix F).  The attitude items about risky sexual 
behavior that showed significance were (a) agreement (p = .019) and disagreement (p = 
.034) with the statement, I have risky sexual behaviors that need changing and (b) 
agreement (p = .033) and disagreement (p = .012) with the statement, I have risky drug 
use behaviors that need changing.  When running Tau-b correlation analysis on HIV 
testing and attitudes of risky sexual behavior, there was a weak, positive association 
(Tau-b = .097, p = .013) with HIV testing and the women who agreed with the statement, 
I have risky sexual behaviors that need changing.  The analysis showed a weak, inverse 
association (Tau-b = .092, p = .011) with HIV testing and the women who agreed with 
the statement, I have risky drug behaviors that need changing. The Wald criterion 
revealed that women who agreed with the statement, I have risky drug behaviors that 
need changing, was a significant predictor for HIV testing (Wald = 4.088, df = 1, p = 
.043; see Appendix F).  The model showed that women who agree with the statement, I 
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have risky drug behaviors that need changing, were 1.83 times (83%) more likely to 
decide to be HIV tested (Exp [B] = 1.829, 95% CI [1.018,3.288]; see Appendix F).  
Research question 5. Are there interactions between women’s knowledge to prevent 
HIV, attitudes about risky sexual behavior, and the women’s decision to have HIV 
testing? Analysis using the Hosmer and Lemeshow test demonstrated an 88.4% ability to 
predict HIV testing. According to the model summary, the model showed an increase 
variation of 15.3% that the women’s decision to have HIV testing is influenced by the 
women’s knowledge to prevent HIV and attitudes about risky sexual behavior 
(Nagelkerke R
2
 = .153; see Appendix G). When combining the women’s knowledge to 
prevent HIV and attitudes about risky sexual behavior, the Wald criterion revealed that 
the item, I have risky sexual behaviors that need changing, became a significant predictor 
in the combined model (Wald = 4.102, df = 1, p =.043; see Appendix G).  The model 
demonstrated that women who agreed with the attitude statement about risky sexual 
behavior item, I have risky sexual behaviors that need changing, were twice as likely to 
decide to have HIV testing (Exp[B]) = 2.068, 95% CI [1.024, 4.177; see Appendix G). 
The model also demonstrated that women who agreed with the attitude statement about 
risky sexual behavior, I have risky drug behaviors that need changing, was significant 
demonstrating an increase as a predictor for the women’s decision to be HIV tested (Wald 
= 3.728, df = 1, p = .053; see Appendix G).  The model showed the women who agreed 
with the statement, I have risky drug behaviors that need changing, were almost twice as 
likely to decide to be HIV tested. The model also demonstrated that women who agreed 
with the knowledge item, asked partner if HIV positive, was significant and showed an 
increase as a predictor for the women’s decision to be HIV tested (Wald = 10.582, df = 1, 
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p = .001; see Appendix G).  The model showed that women who, asked partner if HIV 
positive, were 1.3 times more likely to decide to have HIV testing (Exp [B] = 1.303, 95% 
CI [1.111, 1.529; see Appendix G).  
Research question 6. Is there difference in women who engage in sex trading versus 
women who do not engage in sex trading and their decision to have HIV testing?  On the 
WU-RBA-W, women were asked: (a) if they ever traded sex to get drugs or alcohol (yes, 
no); (b) how many times in the past four months they traded sex to get drugs or alcohol; 
(c) more specifically (yes, no), in the last four months had they ever traded sex for 
alcohol, marijuana or hashish, crack or cocaine, heroin, heroin and cocaine mixed 
together (known as speedball), amphetamines (speed or uppers), ecstasy (GHB or other 
club drugs), and other drugs (d) had they ever traded sex to get money, food, a place to 
stay, or clothes (yes, no); and (e) how many times in past four months they traded sex for 
money, food, a place to stay, or clothes. Descriptive statistics were stratified by age 
groups to analyze the responses of the women.  
Trading sex for drugs or alcohol. Of the 751 women who responded to the question 
of ever trading sex for drugs or alcohol, 273 (36.4%) women responded yes and 478 
(63.6) women responded no. The age category of women who showed greater percentage 
of women who reported trading sex for alcohol or drugs or alcohol were 74 (42.0%) 
women aged 25 to 34 years and 163 (42.9%) women aged 35 to 44 years. In contrast, the 
age category of women with the smallest percentage who reported trading sex for alcohol 
or drugs was 4 (4.4%) women aged 18 to 24 years (see Table 7).   
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Table 7 
Trading Sex for Drugs or Alcohol  
 Yes No Total 
Age category n % n %  
18 - 24 4 4.4 86 95.6 90 
25 - 34 74 42.0 102 58.0 176 
35 - 44 163 42.9 217 57.1 380 
45 - 54 29 31.9 62 68.1 91 
55 - 64 3 23.1 10 76.9 13 
65 - 65+ 0 0.0 1 100 1 
Total 273 36.4 478 63.6 751 
 
Number of times, past four months, traded sex for drugs or alcohol.  The number 
of times the women traded sex for drugs or alcohol ranged from 1 to 976. Of the women 
who responded the majority 113 (85.0%) reported one to 20 times. The average median 
of trading sex for drugs or alcohol using the frequency one to 20 times was 3.0 times. The 
median was used with the frequency on one to 20 times due to skewness with the large 
numbers.   
Traded sex for alcohol in last four months for specific drugs. Of 273 women who 
responded to trading sex for drugs or alcohol, 131 to 132 women aged 18 to 54 years 
responded to the question about trading sex for  alcohol, marijuana or hashish, crack or 
cocaine, heroin, heroin and cocaine mixed together known as speedball, amphetamines or 
speed or uppers, Ecstasy, GHB, or other drugs (see Table 8).  
Only 16 (10.0%) women traded sex for alcohol. There were only 5 (13.4%) 
women aged 25 to 34 who responded yes to trading sex for marijuana/hashish. The 
majority of the women 124 (94.7%) in all age categories responded yes to trading sex for 
crack/cocaine (see Table 8). Few women in all age categories traded sex for heroin, 
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heroin and cocaine mixed together (speedball), amphetamines or speed uppers, ecstasy 
GHB or other club drugs, and other drugs (see Table 8).   
Table 8  
Traded Sex for in Past Four Months for Specific Drugs by Age Categories 
 Alcohol Marijuana 
or hashish 
Crack 
or 
Cocaine 
Heroin Heroin & 
Cocaine 
mix 
together 
speedball 
Ampheta-
mines 
speed or 
uppers 
Ecstasy 
GHB or 
other 
club 
drugs 
Other 
drugs 
Age 
category 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
18 - 24 2 2 2 2 2 2 2 2 
  Yes 
 
  No 
0 
(0.0) 
2 
(100) 
0 
(0.0) 
2 
(100.0) 
2 
(100.0) 
0 
(0.0) 
1 
(50.0 
1 
(50.0) 
0 
(0.0) 
2 
(100.0) 
0 
(0.0) 
2 
(100.0) 
0 
(0.0) 
2 
(100.0) 
0 
(0.0) 
2 
100.0) 
25 - 34 37 37 37 37 37 37 37 37 
  Yes 
 
  No 
4 
(10.8) 
33 
(89.2) 
5 
(13.5) 
32 
(86.5) 
34 
(91.9) 
3 
(8.1) 
1 
(2.7) 
36 
(97.3) 
0  
(0.0) 
37  
(100.0) 
0  
(0.0) 
37  
(100.0) 
0  
(0.0) 
37 
(100.0) 
0 
 (0.0) 
37 
(100.0) 
35 - 44 83 82 82 82 82 82 82 82 
  Yes 
 
  No 
11 
(13.3) 
72 
(86.7) 
0 
(0.0) 
82  
(100.0) 
78  
(95.1) 
4 
(4.9) 
2 
(2.4) 
80 
(97.6) 
0  
(0.0) 
82 
(100.0) 
1  
(1.2) 
81 
(98.8) 
1  
(1.2) 
81 
(98.8) 
2 
(2.4) 
80 
(97.6) 
45 -54 10 10 10 10 10 10 10 10 
  Yes 
 
  No 
1 
(10.0) 
9 
(90.0) 
0 
(0.0) 
10 
(100.0) 
10 
(100.0) 
0  
(0.0) 
0 
(0.0) 
10 
(100.0) 
0 
(0.0) 
10 
(100.0) 
0 
(0.0) 
10 
 (100.0) 
0 
(0.0) 
10 
(100.0) 
0 
(0.0) 
10 
(100.0) 
Total 132 131 131 131 131 131 131 131 
  Yes 
 
  No 
16 
(10.0) 
116 
(90.0) 
5 
(3.8) 
12 
6 (96.2) 
124 
(94.7) 
7  
(5.3) 
4 
(3.1) 
127 
(96.9) 
0 
(0.0) 
131 
(100.0) 
1 
 (0.8) 
130 
 (99.2) 
1  
(0.8) 
130 
(99.2) 
2  
(1.5) 
129 
(98.5) 
 
Traded sex for money, food, a place to stay, or clothes. There were 750 women who 
responded to trading sex for money, food, place to stay, and clothes. Approximately half 
of the women 85 (48.3%) aged 25 to 34 years and 191 (50.4%) women aged 35 to 44 
years traded sex for money, food, a place to stay, or clothes (see Table 9). Specifically, 
there were 326 (43.5%) women who traded sex for money, 130 (17.3%) women who 
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traded sex for food, 109 (14.5%) who traded sex for place to stay, and 51 (6.8%) traded 
sex for clothes (see Table 10).  
Table 9 
Trading Sex for Money, Food, Place to Stay, or Clothes 
 Yes No  
Age category n % n % Total 
18 - 24 8 8.9 82 91.1 90 
25 - 34 85 48.3 91 51.7 176 
35 - 44 191 50.4 188 49.6 379 
45 - 54 39 42.9 52 57.1 91 
55 - 64 4 30.8 9 69.2 13 
65 - 65+ 1 100.0 0 0.0 1 
Total 328 43.7 422 56.3 750 
 
Number of times, past four months, traded sex for money, food, a place to stay, or 
clothes. The number of times the women traded sex for money, food, place to stay, or 
clothes frequency ranged from 1 to 880 times. Of the women who responded, the 
majority 134 (86.5%) responded one to 30 times.  The average median of trading sex for 
money, food, place to stay, and clothes using the frequency of one to 30 was 4.0 times. 
The median was used with the frequency of one to 30 times due to the skewness with the 
large numbers. 
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Table 10  
Traded Sex for Money, Food, Place to Stay, and Clothes by Age Categories 
 Money  Food Place to stay Clothes 
Age 
category 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
18 - 24 90 90 90 90 
  Yes 
  No 
8 (8.9) 
82 (91.1) 
2 (2.2) 
88 (97.8) 
5 (5.6) 
85 (94.4) 
3 (3.3) 
87 (96.7) 
25 - 34 176 176 176 176 
  Yes 
  No 
85 (48.3) 
91 (51.7) 
31 (17.6) 
145 (82.4) 
30 (17.0) 
146 (83.0) 
14 (8.0) 
162 (92.0) 
35 - 44 379 379 379 379 
  Yes 
  No 
191 (50.4) 
188 (49.6) 
79 (20.8) 
300 (79.2) 
61 (16.1) 
318 (83.9) 
26 (6.9) 
353 (93.1) 
45 -54 91 91 91 91 
  Yes 
  No 
39 (42.9) 
52 (57.1) 
14 (15.4) 
77 (84.6) 
11 (12.1) 
80 (87.9) 
7 (7.7) 
84 (92.3) 
55 - 64 13 13 13 13 
  Yes 
  No 
3 (23.1) 
10 (76.9) 
4 (30.8) 
9 (69.2) 
2 (15.4) 
11 (84.6) 
1 (7.7) 
12 (92.3) 
65 -65+ 1 1 1 1 
  Yes 
  No 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
0 (0.0) 
1 (100.0) 
Total 750 750 750 750 
  Yes 
  No 
326 (43.5) 
424 (56.5) 
130 (17.3) 
620 (82.7) 
109 (14.5) 
641 (85.5) 
51 (6.8) 
699 (93.2) 
 
Trading sex for alcohol or drugs and HIV testing. Cross tabulation was used to 
describe and analyze women’s responses related to sex trading. Of the 273 women who 
said yes to trading drugs for alcohol, marijuana or hashish, crack or cocaine, heroin, 
heroin and cocaine mixed together (known as speedball), amphetamines (speed or 
uppers), Ecstasy (GHB or other club drugs), and other drugs, only 132 answered the item 
about alcohol and 131 provided responses for the specific drugs. Categorical (yes, no) 
responses of women who had HIV testing and who reported number of HIV tests (0, 1 to 
2, 3 to 4, 5 to 6, 7 to 8, 9 to 10 and greater than 10) were women who traded sex for 
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alcohol, marijuana or hashish, crack or cocaine, heroin, heroin and cocaine mixed 
together (known as speedball), amphetamines (speed or uppers), Ecstasy (GHB or other 
club drugs), and other drugs were analyzed.  
There were 132 women who responded yes or no to trading sex for alcohol and 
yes or no to HIV testing and 131 who responded yes or no to trading sex for specific or 
other drugs and yes or no to HIV testing. Trading sex for crack or cocaine had the 
majority 117 (94.6%) of women who said yes to HIV testing (see Table 11).  
Table 11 
Trading Sex for Alcohol, Specific, or other Drugs and HIV Tested 
 HIV Tested 
 Yes  No   
Trading sex for alcohol, specific, or other 
drugs 
n 
(%) 
n 
(%) 
Total 
n 
Alcohol 124  8 132 
  Yes 
  No 
14 (87.5) 
110 (84.8) 
2 (12.5) 
6 (5.2) 
16  
116 
Marijuana or hashish 124 7 131 
  Yes 
  No 
5 (100.0)  
119 (94.4) 
0 (0.0) 
7 (5.6) 
5 
126 
Crack/Cocaine 124 7 131 
  Yes 
  No 
117 (94.6) 
7 (100.0)  
7 (5.3) 
0 (0.0) 
124 
7 
Heroin 124 7 131 
  Yes 
  No 
4 (100.0) 
120 (94.5) 
0 (0.0) 
7 (5.5) 
4 
127 
Heroin and cocaine mixed together, speedball 124 7 131 
  Yes 
  No 
0 (0.0) 
124 (94.7) 
0 (0.0) 
7 (5.3) 
0 
131 
Amphetamines or speed or uppers 124 7 131 
  Yes 
  No 
0 (0.0) 
124 (95.4) 
1 (100.0) 
6 (4.6) 
1 
130 
Ecstasy, GHB or other club drugs 124 7 131 
  Yes 
  No 
0 (0.0) 
124 (95.4) 
1 (100.0) 
6 (4.6) 
1 
130 
Other Drugs 2 129 131 
  Yes 
  No 
1(0.8) 
1 (14.3) 
6 (85.7) 
123 (99.2) 
7 
124 
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There were 132 women who responded yes or no to trading sex for alcohol, yes or no 
to HIV testing, and number of times tested. There were 131 who responded yes or no to 
trading sex for specific or other drugs, yes or no to HIV testing, and number of times 
tested. Of the 16 (12.1%) women who traded sex for alcohol, only two did not have an 
HIV test, 11 had one to six HIV tests and one had greater than 10 tests. The majority of 
women who traded sex for specific or other drugs traded sex for crack or cocaine.  Of the 
124  women, 117 (94.4%) who responded yes to trading sex for crack or cocaine reported 
having had HIV tests ranging from one to greater than 10 (see Table 12).   
Table 12 
Trading Sex for Alcohol, Specific, or other Drugs and Number of HIV Tests  
 Number of HIV tests  
Trade sex No 1- 2  3 - 4 5 – 6 7 - 8 9 - 10 > 10 Total 
 n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Alcohol 8  46 39 19 8 5 7 132 
  Yes 
  No 
2 (25.0) 
6 (75.0) 
3  (6.5) 
43 (93.5) 
5 (12.8) 
34 (87.2) 
3 (15.8) 
16 (84.2) 
0  (0.0) 
8 100.0) 
0 (0.0) 
5(100.0) 
3 (42.9) 
4 (57.1) 
16 (12.1) 
116 (87.9) 
Marijuana or 
hashish 
7 46 39 19 8 5 7 131 
  Yes 
  No 
0 (0.0) 
7(100.0) 
3 (6.5) 
43 (93.5) 
0 (0.0) 
39 (100.0) 
0 (0.0) 
19 (100.0) 
1 (12.5) 
7 (87.5) 
1 (20.0) 
4 (80.0) 
0 (0.0) 
7 (100.0) 
5 (3.8) 
126 (96.2) 
Crack/cocaine 7 46 39 19 8 5 7 131 
  Yes 
  No 
7 (100.0) 
0 (0.0) 
44 (95.7) 
2 (4.3) 
36 (92.3) 
3 (7.7) 
18 (94.7) 
1 (5.3) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
6 (85.7) 
1 (14.3) 
124 (94.7) 
7 (5.3) 
Heroin 7 46 39 19 8 5 7 131 
  Yes 
  No 
0 (0.0) 
7 (100.0) 
3  (6.5) 
43 (93.5) 
0 (0.0) 
39 (100.0) 
1 (5.3) 
18 (94.7) 
0 (0.0) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
7 (100.0) 
4 (3.1) 
127 (96.9) 
Heroin and 
cocaine  
7 46 39 19 8 5 0 131 
  Yes 
  No 
0  (0.0) 
7 (100.0) 
0 (0.0) 
46 (100.0) 
0 (0.0) 
39 (100.0) 
0 (0.0) 
19 (100.0) 
0 (0.0) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
7 (100.0) 
0 (0.0) 
131 (100.0) 
Amphetamine
speed uppers 
7 46 39 19 8 5 7 131 
  Yes 
  No 
1 (14.3) 
6  (85.7) 
0 (0.0) 
46 (100.0) 
0 (0.0) 
39 (100.0) 
0 (0.0) 
19 (100.0) 
0  (0.0) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
7 100.0) 
1 (0.8) 
130 (99.2) 
Ectasy, GHB, 
or other club 
drugs 
7 46 39 19 8 5 7 131 
  Yes  
  No 
1  (14.3) 
6  (85.7) 
0  (0.0) 
46 (100.0) 
0  (0.0) 
39 (100.0) 
0 (0.0) 
19 (100.0) 
0 (0.0) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
7 (100.0) 
1 (0.8) 
130 (99.2) 
Other drugs 7 46 39 19 8 5 7 131 
  Yes 
  No 
1 (14.3) 
6 (85.7) 
1 (2.2) 
45(97.8) 
0 (0.0) 
39 (100.0) 
0(0.0) 
19 (100.0) 
0 (0.0) 
8 (100.0) 
0 (0.0) 
5 (100.0) 
0 (0.0) 
7 (100.0) 
2 (1.5) 
129 (98.5) 
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Independent sample t-tests were run to determine if there were significant 
differences in women who responded yes and women who responded no to trading sex 
for alcohol or specific drugs (see Appendix D).  Compare means tests were run to 
validate means from t-test results and to identify median number of HIV tests. This was 
done because of the wide range of HIV tests reported. Of the sample of 751 women, 273 
women reported trading sex for alcohol or drugs.  Of the 273 women who reported 
trading sex for alcohol or drugs, 257 (94.1%) reported having HIV testing (M = 4.58,  
SD = 7.12, Mdn = 3). Of 131 women who responded yes or no to trading sex for specific 
drugs, 124 (94.6%) reported trading sex for crack or cocaine, 7 (5.6%) women reported 
no HIV testing, 117 (94.4%) women reported yes to HIV testing with (M = 4.14, 
SD 4.33, Mdn = 3; see Table 12; see Appendix D). 
Traded sex for money, food, a place to stay, or clothes and HIV testing. There 
were 749 women who responded yes or no to trading sex for money, food, place to stay, 
and clothes and yes or no to HIV testing. Of the women who traded sex for money, food, 
place to stay, or clothes; 93.6% or greater had HIV testing (see Table13). Interestingly, 
there were a large number of women (87.0% to 89.3%) who responded no to trading sex 
also had HIV testing (see Table 13).   
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Table 13 
Traded Sex for Money, Food, Place to Stay, or Clothes and HIV Tested 
 HIV tested 
 Yes No  
Trade sex for: n (%) n (%) Total 
Money   749 
  Yes 
  No 
305 (93.6) 
368 (87.0) 
21 (6.4) 
55 (13.0) 
326 
423 
Food   749 
  Yes 
  No 
122 (93.8) 
551 (89.0) 
8 (6.2) 
68 (11.0) 
130 
619 
Place to Stay   749 
  Yes 
  No 
107 (98.2) 
566 (88.4) 
2 (1.8) 
74 (11.6) 
109 
640 
Clothes   749 
  Yes 
  No 
49 (96.1) 
624 (89.3) 
2 (3.9) 
74 (10.6) 
51 
698 
 
There were 749 women who responded yes or no to trading sex for money, food, 
place to stay, and clothes and the number of time they had an HIV test. The largest 
number of women, 326 (43.5%) who responded yes to trading sex for money reported 
having had HIV tests ranging from zero to greater than 10 (see Table 14).  Women who 
responded yes to trading sex for food 130 (17.5%), a place to stay 109 (14.5%), and 
clothes 51 (6.8%) had low percentages for the number of HIV tests (see Table 14).  
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Table 14 
Traded Sex for Money, Food, Place to Stay, or Clothes and Number of HIV Tests 
 HIV testing   
Trade  No 1- 2 3 - 4 5 - 6 7-8 9 - 10 > 10 Total 
sex for: n (%) n (%) n (%) n (%) n (%) n (%) n (%) n 
Money 76 295 199 91 22 30 26 749 
  Yes 
  No 
21 (6.4) 
55 13.0) 
104 (31.9) 
191 (45.1) 
99 (30.4) 
100 (23.6) 
53 (16.3) 
38 (9.0) 
12 (3.7) 
10 (2.4) 
19 (5.8) 
11(2.6) 
18 (5.5) 
18 (4.3) 
326 (43.5) 
423 (56.5) 
Food 77 295 199 91 22 30 36 749 
  Yes 
  No 
8 (6.2) 
68 11.0) 
35 (26.9) 
260 (42.0) 
46 (35.4) 
153 (24.7) 
19 (14.6) 
72 (11.6) 
4 (3.1) 
18 (2.9) 
9 (6.9) 
21 (3.4) 
9 (6.9) 
27 (4.4) 
130 (17.4) 
619  (82.6) 
Place 
to Stay 
 
76 
 
295 
 
199 
 
91 
 
2 
 
30 
 
36 
 
749 
  Yes 
  No 
2 (1.8) 
74 11.6) 
25 (22.9) 
270 (42.1) 
40 (36.7) 
159 (24.8) 
22 (20.2) 
69 (10.8) 
5 (4.6) 
17 (2.7) 
7 (6.4) 
23(3.6) 
8 (7.3) 
28 (4.4) 
109 (14.5) 
640 (85.4) 
Clothes 76 295 199 91 22 30 36 749 
  Yes 
  No 
2 (3.9) 
74 (10.6) 
14 (27.5) 
281 (40.3) 
17 (33.3) 
182 (26.1) 
12 (23.5) 
79 (11.3) 
1 (2.0) 
21 (3.0) 
2 (3.9) 
28 (4.0) 
3 (5.9) 
33 (4.7) 
51 (6.8) 
698 (93.2) 
 
An independent sample t-tests were run to determine if there was a significant 
difference in women who responded yes and women who responded no to trading sex for 
alcohol, specific drugs, other drugs, money, food, a place to stay, or cloths (see Appendix 
D).  There was a significant difference in the number of HIV tests for women who 
responded yes to trading sex for money (M = 4.84, SD = 4.32) and those who responded 
no to trading sex for money (M = 3.14, SD = 4.33); t (452) = -3.27, p = .001. There was 
also a significant difference in the number of HIV tests for women who responded yes to 
trading sex for food (M = 5.62, SD = 10.08) and the women who responded no to trading 
sex for food (M = 3.51, SD = 5.49); t (145) = -2.32, p = .01. Last, a significant difference 
in the number of HIV tests for women who reported yes to trading sex for a place to stay 
(M = 6.12, SD = 10.52) and the women who reported no to trading sex for place to stay 
(M = 3.50, SD = 5.54); t (118) = - 2.54, p = .01. 
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Chapter V 
Introduction 
 This chapter presents a summary of the problem, the design and purpose, and a 
discussion of the results to the research questions.  A discussion of limitations of the 
study, implications for nursing practice, and recommendations for future nursing science 
and research are also presented.   
Summary of Problem 
According to the CDC (2013e), in 2011, there were 136,690 African American 
women living with HIV infection and 5,311 African American women with initial test 
results classified as AIDS.  African American women accounted for 6,623 (63%) of new 
female HIV cases reported in 2011 (CDC, 2013a).  In 2010, AIDS was ranked among the 
top 10 causes of mortality for African American women aged 25 to 64 years (CDC, 
2013c). High risk heterosexual behavior accounted for 74% of the HIV/AIDS cases 
among African American women (CDC, 2008). Routine HIV testing may provide for 
earlier recognition of the virus, and referral for disease management that may prevent the 
acceleration of the HIV virus to AIDS.  With the rising numbers of African American 
women testing positive for HIV, additional research is needed to determine factors that 
will influence African American women to seek HIV testing. Therefore, it is important to 
study if African American women’s knowledge of risk behaviors can influence early HIV 
testing.  
Summary Design and Purpose 
This study design used a secondary data analysis of existing data collected in a 
study conducted at a large Midwestern University School of Medicine that investigated 
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the efficacy of a female oriented model delivered at discrete intervals to decrease drug 
use and sexual risks behaviors (Cottler, 2006). The purposes of this investigation were to 
examine this existing data set from a sample of African American women with a history 
of drug use and who are at high risk to acquire or transmit HIV and/or STDs to determine 
the women’s knowledge and attitudes about risky sexual behaviors, factors influencing a 
decision to have HIV testing, and the influence of sex trading on the decision to have 
HIV testing.   
Discussion of Results 
Research question 1. This investigation sought to determine what knowledge 
women have about actions before and after sex to prevent acquiring HIV or STDs? This 
study found 322 (48.7%) cleansed with soap prior to sex, more than half of the women 
416 (62.9%) cleansed with soap after sex, and almost half cleansed with douching after 
sex to prevent HIV or STDs. These findings are inconsistent with the findings from a 
Younge, Salem, Bybee (2010) reported from a sample 196 women only 19 (10%) 
douched or washed after sex. Younge et al. did not report on specific findings of 
cleansing with soap before sex to prevent HIV or STDs. 
This study also found that 397 (60.1%) over half of the women did not allow their 
partner to ejaculate as action to prevent HIV or STDs. This study findings were much 
higher than Young, Salem, and Bybee’s (2010) study findings who reported only 7 
(4.0%) of the women from a sample of 196 did not allow their partner to ejaculate.  
 In addition, this study found 335 (50.7%) of the women urinated after sex to 
prevent HIV or STDs. Although the results are low, it was interesting to find in current 
study that 76 (11.5%) of the women were taking antibiotics after sex to prevent HIV or 
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STDs. This finding is consistent with a study in Thailand of men who took antibiotics to 
prevent HIV (Khamboonruang, et al., 1996). Although men in this study were less likely 
to be HIV infected, the effect of taking antibiotics to prevent HIV is unknown 
(Khamboonruang, et al.) 
The study found almost half, 310 (46.9%), of the women were having sex with 
partners they deemed as healthy partners to prevent HIV or STDs. This is consistent with 
Jarama et al.  (2007) who reported the unknown risk behavior among African American 
women is the result of trust in their partner. This is also consistent with other researchers 
who noted that, although health departments have worked to educate the public about 
HIV risks, many African American women perceive themselves as low risk, especially if 
African American women believe they are in a monogamous relationship (Hobfoll, 
Jackson, Lavin, Britton, Shepherd, 1993; Mallory, 2008; McNair & Prather, 2004). 
Research question 2. This investigation aimed to determine the attitudes about 
HIV/AIDS and risky sexual behaviors. In this study almost half of the women, 374  
(49.8 %), identified that a high risk behavior to contract HIV/AIDS was sharing needles; 
344 (45.8%) reported not using condoms as a risky sexual behavior; and the majority 639 
(85.1%) of the women believed having sex with one partner was safer than having sex 
with two or more partners consistent with CDC (2008) definition of risky sexual 
behaviors. These findings are consistent with study of unmarried, heterosexual African 
American women (N = 325) aged 18 to 61 years who participated in the five week Sistas 
Informing Sistas about the Topic of AIDS (SISTA) program (Corneille et al. (2008). The 
findings suggest that older African American women may be at greater risk for HIV 
because they perceived their principal partner as being opposed to condom use, younger 
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African American women were more likely to use condoms in current or past 
relationships; yet all women reported they were less likely to use condoms with principal 
partner (Corneille et al.). The investigation findings are also consistent with study of 398 
African American unmarried heterosexual women reported an unfavorable attitude 
toward the use of condoms (Belgrave et al., 2010). 
Although this study found that majority 639 (85.1%) of the women believed 
having sex with one partner is safer than having sex with two or more partners; 112 
(14.9%) of the women disagreed. In the current study, a key finding was that 255 (34%) 
of the women agreed that they had risky sexual behaviors they needed to change. For 
example, 112 (14.9%) of the women disagreed that having sex with one partner is safer 
than having sex with two or more partners; 508 (67.6%) believed their steady partner had 
cheated on them; and 461 (61.5%) reported having cheated on one of their steady 
partners is consistent with CDC (2008) identified risky sexual behaviors. These findings 
lends some credence to Moreno et al. (2011) findings that African American women were 
1.5 times more likely than Latina women to report five or more sex partners in a life time. 
In study by Wright et al. (2007) African Americans were twice as likely as Caucasians to 
report multiple sex partners. In addition, Atkinson et al. (2007) findings of 497 African 
American men and 195 African American women had an average number of sex partners 
of 9.7 with median of five partners and the women had significantly more partners than 
the men.    
This study also found more than half of the 476 (63.4%) women believed they 
were in control of whether or not they get HIV. This finding is consistent with  an 
exploratory study by Jarama et al. (2007) of 51 African American women aged 18 to 49 
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years, the women in this investigation all believed they had control within their sexual 
relationship and voiced assurance of being comfortable to discuss safer sex with partners. 
Only 189 (25.2%) of the women in current study had agreed with getting HIV as their 
destiny. Although the study found 375(49.9%) women believed other people play part in 
getting HIV and 438 women (58.3%) believed getting HIV depends on their partner. This 
study also showed 631(84.0%) of the women believed their own behaviors determine if 
they got HIV, 375(49.9%) women believed other people played a part in getting HIV.  
Research question 3. This study found that women’s knowledge about risky 
sexual behavior influenced her decision to have HIV testing. In this investigation, there 
was a significant difference in the number of HIV tests for women who asked their 
partner if they were HIV positive (M = 4.65, SD = 8.48) and who asked their partner 
about their sex history (M = 4.66, SD = 8.04) compared to women who did not ask their 
partner if they were HIV positive (M = 2.87, SD = 3.20); t (539) = -3.79,  
p = 0.00 and who did not ask their partner about their sex history (M = 3.40, SD = 5.93);  
t (480) = -2.21, p = .03 (see Appendix B). These findings lend some support to 
researchers who reported African American women were acculturated to not inquire 
about a partner’s sex history, negotiate condom use, or discuss sex in general (Harris et 
al., 2013; Jarama et al., 2007; Whyte, Whyte, & Cormier, 2008). In contrast Longmore, 
Johnson, Manning, and Giordano (2013) reported that young women found it difficult to 
communicate about sex or had more verbal disputes with their partner about their 
relationship were more likely to be HIV tested.  
Further analysis using the binary logistic regression model predicted a small 
percentage of the women’s decision to be HIV tested was influenced by their knowledge 
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of risky sexual behaviors (Naegelkerke R
2
  = .100; see Appendix E).  Specifically this 
investigation found women who had asked their partner if they were HIV positive were 
1.26 times more likely to decide to be HIV tested (Exp [B] = 1.265, 95% CI [1.024, 
4.177]; see Appendix E). These results were similar to study by Longmore et al. (2013) 
of HIV testing among 655 young adults (mean age 20.6; 372 women, 293 men), who 
reported their partner having a history of numerous past sexual partners were more likely 
to be HIV tested; and 65% of the women who reported their partner not being 
monogamous in their current relationship were HIV tested.  Specifically, Longmore et al. 
concluded young women’s own risk behaviors together with their partners’ risk behaviors 
were associated with HIV testing.  
Research question 4. This study found that women’s attitudes about risky sexual 
behavior influence her decision to have HIV testing. This study found there was a 
significant difference in the number HIV tests for women who reported cheating on one 
of their steady sex partners (M = 4.25, SD = 7.49) and the women who did not cheat on 
one of their steady sex partners (M = 3.28, SD = 4.67); t (747) = - 2.19,  
p = .03 (see Appendix C). There was also a significant difference for women who agreed 
that their own risky sexual behaviors determined whether they contract the HIV virus (M 
= 4.06, SD = 7.00) compared to the women who disagreed (M = 2.98, SD = 3.37); t (288) 
= 2.50, p = .01 (see Appendix C).  
In this investigation the binary logistic regression model predicted a minor  
percentage of the women’s decision to be HIV tested was influenced by the women’s 
attitudes to about risky sexual behavior (Nagelkerke R
2
 = .043; see Appendix F). 
Specifically this investigation found that women who agreed with the statement, I have 
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risk drug behaviors that need changing were predicted to be twice as likely to be HIV 
tested (Exp [B] = 1.829, 95% CI [1.018, 3.288]; see Appendix F).  These results are 
consistent with Medina (2009) study of 56 women who also reported a small number of 
women (8, 14.6%) were HIV tested as result of an identified theme, apprehension of 
personal drug use. Spiller, Broz, Wejnertm, Nerlanderm, and Bailey (2015) also reported 
from a 2012 surveillance of HIV behavior, there was only an 11% prevalence rate among 
intravenous drug users who were HIV tested. Interestingly, of the 10,002 women (32%) 
in the study sample, 63% reported having been HIV tested in the previous 12 months 
(Spiller et al.)   In contrast, a Croatian retrospective study by Matković Puljić, Kosanović 
Ličina, Kavić, and Nemeth Blažić (2014) found both men and women who self-reported 
intravenous drug use were predicted to be almost three times as likely to obtain repeated 
HIV testing.  
Research question 5. This study sought to determine if there were interactions 
between women’s knowledge to prevent HIV, attitudes about risky sexual behavior, and 
the women’s decision to have HIV testing. This investigation found the binary logistic 
regression model predicted an increased to 15.3% variation in the decision to be HIV 
tested is influenced by the women’s knowledge to prevent HIV and attitudes about risky 
sexual behavior (Nagelkerke R
2
 = .153, see Appendix G). For example, the women 
agreed with the knowledge items, asked their partner if they are HIV positive, were 1.3 
times more likely to be HIV tested,  and women who agree with the knowledge 
statement, I have risky drug behaviors that need changing, increased to 1.9 times more 
likely to be HIV tested. Interestingly, the interactions between women’s knowledge to 
prevent HIV and attitudes about risky sexual behavior emerged as an additional and more 
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significant predictor; women who agreed with the attitude statement, I have risky sexual 
behavior that need changing, were twice as likely to be HIV tested (Exp [B] = 2.068, 
95% CI [1.024, 4.477]; see Appendix G). These findings suggest that women in this 
study who were aware of their risky sexual behaviors were HIV tested more often than 
those women who disagree with the knowledge items of having risky sexual behaviors. 
Thus, the act of engaging in risky sexual behaviors may have been a factor that 
influenced the women to be HIV tested. These findings are similar to a recent qualitative 
study by Teitelman, Calhoun, Duncan, Washio, and McDougal (2015) who reported 30 
African American women who knowingly engaged in risky sexual behaviors sought HIV 
testing. According to Teitelman et al. qualitative findings, 30 African American women 
aged 18 to 25 years disclosed being HIV tested as a strategy to reduce HIV risk.  A theme 
that emerged was when women were unable to negotiate condom use or their partner’s 
willingness to be monogamous, these women recognized their HIV risk and proposed an 
agreement that both would be HIV tested in order to establish trust and to establish 
devotion to the relationship (Teitlman et al., 2015).   
  Research question 6. Lastly, this study found a difference in women who 
engage in sex-trading versus women who do not engage in sex-trading and their decision 
to have HIV testing. This investigation found 273 (36.4%) of the women reported trading 
sex for alcohol and drugs; 257 (94.1%) reported having HIV testing with a median of 
three HIV tests (M = 4.58, SD = 7.12, Mdn = 3). Of the 273 women who reported trading 
sex for alcohol and drugs, 132 responded to the survey item asking about trading sex for 
alcohol and 131 women responded to the survey items about trading sex for specific 
drugs. Interestingly, 74 (42.0%) women aged 25 to 34 years and 163 (42.9%) women 
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aged 35 to 44 years had a higher percentage of trading sex for alcohol or drugs (see Table 
7). This finding is consistent with the Wright et al. (2007) who reported that from a 
sample of 266 rural women, 100 (37.6%) reported trading sex for money or drugs, but  
lower than Dolwick-Grieb, Davey-Rothwell, and Lakin (2012) findings, from a sample of 
567 urban African American women 375 (66.1%) women traded sex to obtain drugs. In 
contrast, this investigation found a high percentage of women, 124 (94.6%) a sample of 
131 women, who traded sex for crack or cocaine. This finding was higher than Cavazos-
Rheg et al. (2009) who reported that 78 (62.4%) from a sample of 125 women traded sex 
for cocaine or money. In addition, this investigation also found higher sex trade for crack 
or cocaine than Schӧnnesson et al. (2008) who reported that 59 (42.7%) from a sample of 
138 women who were crack cocaine or users, 59 (42.7%) traded sex for a money or 
drugs, with more than two partners, and had inconsistent condom use. Although 
Schӧnnesson et al. (2008) findings of trading sex for crack or cocaine were lower than 
this investigation, it should be noted these women were aware of their HIV positive 
status. In the current study 117 (94.4%) of the 124 women who traded sex for crack or 
cocaine were HIV tested with a median of 3 HIV tests (M = 4.14, SD = 4.33, Mdn = 3; 
see Appendix D).  
 Overall this study found 328 (43.7%) of the women traded sex for money, 130 
(17.5%) traded sex for food, 109 (14.5%) traded sex for a place to stay, and 51 (6.8%) 
traded sex for clothes.  Likewise, Millay et al. (2009) findings from focus interviews of 
30 women with high risk sex behaviors reported that the women traded sex for money, 
which was used to pay financial obligations or to support drug use.  
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This investigation showed women who traded sex for money, food, place to stay, 
or clothes had higher number of HIV tests with mean number of HIV tests range from 
4.84 to 6.12 compared to women who did not trade sex for money, food, place to stay, or 
clothes with mean number of HIV tests range from 3.14 to 3.51. Women who traded sex 
for food showed the highest average number of HIV tests (M = 5.62, SD = 10.08, see 
Appendix D). These findings suggest that the women who traded sex for money, food, 
place to stay, or clothes knew they were at risk, and sought HIV testing. 
Limitations 
 The findings of this investigation are limited because the sample was all African 
American women, from a lower socio-economic status, and were high risk female drug 
users, from a large Midwest metropolitan area. Thus, the findings can be generalized only 
to population with similar characteristics. Another limitation is the data is older and 
current trends of HIV testing may have changed. Additionally, the level of measurement 
of the data is categorical, which allows for a prediction of categorical outcome, yes or no, 
but statistically inappropriate to predict the number of times to HIV test. 
Implications for Nursing Science and Practice 
Based on the findings of this investigation, the following implications for nursing 
science and practice are presented:  
 It is important for nurses to assess African American women’s high risk 
behaviors for contracting HIV and if they have had HIV testing. Being tested 
for HIV increases the potential for early detection and early treatment. 
 It is important for nurses who provide HIV and STD educational programs to 
assess what knowledge African American women have about actions before 
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and after sex to prevent acquiring HIV or STDs. These preventative actions 
may protect the woman from contracting HIV. 
 Community health nurses need to assess African American women’s 
knowledge to prevent HIV and attitudes about risky sexual behavior, educate 
women about high risk behaviors for HIV, and the importance of HIV testing. 
Women in this investigation who recognized risky drug behavior and risky 
sexual behaviors that need changing were more likely to be HIV tested.  
 It is important for nurses who provide HIV and STD educational programs to 
teach and promote communication skills that help the African American 
women ask their partner about sex history and HIV status. Women who 
communicated with their partner, asked about HIV status, were more likely to 
be HIV tested. 
 Community health nurses need to be aware of the underlying health issues 
surrounding drug and alcohol use and addiction. African American women’s 
cognitive ability may be impaired by alcohol and drugs and may be unable to 
learn or make behavioral changes to prevent HIV. Thus, community nurses 
should encourage African American women with addictive behaviors to seek 
alcohol and drug treatment. 
 Community health nurses need to be aware that African American women 
who are using crack or cocaine have a high incidence of trading sex in order 
to support their need for the drug. Thus there is a greater need for nurses to 
assess specifically the drugs women are using and encourage women who use 
crack or cocaine the importance of being tested for HIV and STDs. 
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 Community health nurses need to be aware that there are African American 
women who trade sex for life essentials such as money, food, a place to stay, 
or clothing. It is important to also note that when women trade sex for drugs, 
need additional nursing support. It is vital for community health nurses to 
bring together a multidisciplinary team to address African American woman’s 
lack of life’s essentials (money, food, place to stay, and clothing); 
psychological support to address the issues surrounding drug use; 
psychological support to address potential emotional abuse as a result of 
trading sex; and community programs aimed to teach life skills and household 
management. 
Implication for Conceptual Model 
The conceptual model, African American Women with Drug Use and HIV 
Testing, was useful to guide this investigation. Based on a review of the literature, this 
conceptual model was designed to identify factors that influence HIV testing among 
African American women with a history of drug use. Thus, this investigator found 
defining the concepts African American women with a history of drug use, drug use 
behaviors, trading sex behaviors, risky sexual behaviors, attitudes about HIV/AIDs and 
risky sexual behaviors, knowledge about actions to prevent getting HIV or STDs, and 
HIV testing were useful for the study of this population. The analysis then provided the 
guide for recommendations for nursing practice and research.  
Recommendations for Future Nursing Science 
Based on the findings of this investigation, the following recommendations for 
nursing research are presented:  
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This study was a homogenous sample of African American women. Future 
studies should include other populations with a history of drug use, including both men 
and women, to determine factors that influence the decision to be HIV tested.  
This study suggests that African American women are able to identify their own 
risky sexual behaviors, their partners’ risky sexual behaviors, and were in control of 
whether or not they could get the HIV virus.  Future research should measure actions of 
African American women with a history of drug or risky sexual behavior use to prevent 
acquiring HIV or STDs, and study nursing interventions that determine if these reduce 
the incidence of HIV or STDs. 
Corneille et al. (2008) reported that lack of communication regarding sexual 
history coupled with need to show trust, put African American women at an unknown 
risk for contracting HIV infection.  In contrast, this investigation found that African 
American women who were able to ask about their partner’s sexual history were more 
likely to be HIV tested. Future research should measure strategies that help African 
American women communicate with their partner about their sexual history (drug use or 
risky sexual behaviors) to determine if using communication skills can reduce the risk of 
HIV and increase HIV testing.    
This investigation found women who agreed that they had risky sexual behavior 
that needed changing were more likely to be HIV tested. Future research should study 
African American women who recognize that they have risky sexual behaviors that need 
changing to determine strategies to help them change these risky sexual behaviors to 
prevent HIV and to encourage HIV testing. 
 Green, Lisa, UMSL 104 
 
This study found HIV testing was influenced by the women’s knowledge to 
prevent HIV and her attitudes about risky sexual behavior. There was also an interaction, 
an increased variation of 15.3%, that the women’s decision to have HIV testing was 
influenced by her knowledge to prevent HIV and attitudes about risky sexual behavior.   
Future studies should assess both African American women’s knowledge to prevent HIV 
and her attitudes about risky sexual behavior. Then design a tailored teaching program 
that increases African American women’s knowledge about HIV, helps her develop 
strategies to reduce risky sexual behaviors, helps her to understand when there is a need 
to be HIV tested, and determine the effectiveness of the tailored teaching program.  
Of the 751 African American women in this investigation, over one third traded 
sex for drugs and alcohol and almost half traded sex for money, food, a place to stay and 
clothes.  Future studies need to determine strategies that ascertain the unique needs of 
African American women, develop and evaluate tailored intervention programs to reduce 
the prevalence of sex trading. These tailored intervention programs should include 
teaching life skills and household management that can facilitate finding housing and 
employment. These tailored intervention programs should also provide interventions for 
drug and alcohol abuse and psychological support for potential emotional abuse.  
Conclusion 
 This study reinforce previous studies that this high risk sample of African 
American women with a history of drug use have some knowledge about actions before 
and after sex to prevent HIV or STDs. Almost half of the women were able to identify 
their risk behaviors, sharing needles, not using condoms, and having sex with one partner 
was safer than with two or more partners. Almost half of the women were having sex 
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with partners they deemed as health partners, consistent with previous studies that 
African American women had trust in their partner and believed they were at low risk for 
HIV. More than half of the women believed they were in control of whether or not they 
get HIV. 
 In contrast to other studies that reported women found it difficult to engage their 
partner in discussion about sex were more likely to be tested, in this study there was a 
significant difference in the number of HIV tests for women who asked there partner if 
they were HIV positive and their sex history compared to women who did not ask these 
questions. Women in this investigation decision to be HIV tested was influenced by their 
knowledge of risky sexual behaviors; this was small but significant relationship.  
This study reinforced previous finding that a minor percentage of the women’s 
decision to be HIV tested was influenced by the women’s attitudes about risky sexual 
behavior. For example, there was a significant difference in the number HIV tests for 
women who reported cheating on one of their steady sex partners and women who did 
not cheat on one of their steady sex partners.  There was also a significant difference for 
women who agreed that their own risky sexual behaviors determined whether they 
contract the HIV virus compared to the women who disagreed.   
 This study lends support to previous studies that previous that African American 
women knowingly engaged in risky sexual behaviors were more likely to be tested. 
Findings from this investigation suggest that women who were aware of their risky 
sexual behaviors were HIV tested more often than those women who disagree with the 
knowledge items of having risky sexual behaviors. This investigation predicted an 
increased to 15.3% variation in the decision to be HIV tested was influenced by the 
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women’s knowledge to prevent HIV and attitudes about risky sexual behavior.  For 
example, the interactions between women’s knowledge to prevent HIV and attitudes 
about risky sexual behavior emerged as an additional and more significant predictor; 
women who agreed with the attitude statement, I have risky sexual behavior that need 
changing, were twice as likely to be HIV tested. 
 Reinforcing previous research, over one third of the African American women in 
this investigation reported trading sex for alcohol and drugs and with a large number of 
women who traded sex for crack or cocaine. Just under half of the women (n = 326, 
43.4%) traded sex for money, food, place to stay, or clothes. In this investigation, women 
who traded sex for money, food, place to stay, or clothes had higher number of HIV tests 
compared to women who did not trade sex for money, food, place to stay, or clothes. 
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Appendix A 
Washington University Risk Behavior Assessment of Women. 
HIV Testing 
TX17 Now I want to ask questions about the test for HIV, the 
virus that causes AIDS. Not counting today, how many 
times, if any, have you had a test for HIV (the AIDS virus)?  
 
 
TIM
ES 
 
 
_ _ _ 
     
Sex Trade: Sex for Money/Drugs/ Food 
SA 45 Have you ever traded sex of any kind or “tricked” to get 
drugs or alcohol?  
NO GO 
TO 
SA48 
 
1 
  YES… 5 
SA46 How many times in the past 4 months, since (DATE 4 
MONTHS AGO), did you trade sex to get drugs or 
alcohol? 
 
 
TIMES 
 
 
_ _ _ 
    
SA47 In the past 4 months did you trade sex for:   
   NO YES 
 A. Alcohol?.................................................................. 1 5 
 B. Marijuana or hashish?.............................................  1 5 
 C. Crack or cocaine?..................................................... 1 5 
 D. Heroin?................................................................... 1 5 
 E. Heroin and cocaine mixed together (e.g. speedball)? 1 5 
 I.  Amphetamines or speed or uppers?......................... 1 5 
 J. Ecstasy, GHB or other club drugs?........................... 1 5 
 K. Some other drug?...................................................... 1 5 
  [SPECIFY:_____________________________]   
     
SA48 Have you ever traded sex to get… NO YES 
 A. Money?....................................................................... 1 5 
 B. Food?.......................................................................... 1 5 
 C. A place to stay?........................................................... 1 5 
 D. Clothes?...................................................................... 1 5 
   
 
  
SA49 How many times have you traded sex in the past 4 
months to get money, food, a place to stay, or clothes? 
 
TIMES 
 
_ _ _ 
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Knowledge: Sexual Activity Before and After Sex 
SA 50. We have heard about some things people do before or 
after sex to keep from getting STDs or HIV. Have you 
done any of these behaviors to keep from getting HIV or 
STDs? 
  
  NO YES 
 a. Washed your genitals before sex with 
soap?.............. 
  
 b. Washed your partner’s genitals before sex with 
soap?..........................................................................
. 
 
1 
 
5 
 c. Washed your genitals after sex with soap? .............  1 5 
 d. Not let your partner ejaculate in 
you?........................ 
1 5 
 e. Douched after sex?.................................................... 1 5 
 f. Urinated after sex?.................................................... 1 5 
 g. Washed your genitals after sex with alcohol?........... 1 5 
 h. Washed your partner’s genitals after sex with 
alcohol?………………………………………….... 
1 5 
 i. Took antibiotics before or after sex? 1 5 
 j. Had sex with only healthy looking 
people?............... 
  
 k. Washed your genitals with bleach or peroxide after 
sex?............................................................................ 
  
 l. Washed your partner’s genitals with bleach or 
peroxide after 
sex?..................................................... 
1 5 
 m. Asked your partners if they are HIV positive?......... 1 5 
 n. Substituted oral sex for vaginal sex?......................... 1 5 
 o. Substituted anal sex for vaginal sex?........................ 1 5 
 p. Asked your partner for their sex history?................. 1 5 
 q. Have you or your partner used ear wax to 
determine if you have an STD?............................... 
 
1 
 
5 
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Attitudes: HIV/AIDS 
HIV1. These questions are about your attitudes toward sex. For each of the 
statements please tell me if you agree, disagree, or are neutral. I want to 
know how you feel right now, not what you feel in the past or what you 
would like to feel. 
   Agree Neutral Disagree 
 A. I have risky sexual behaviors that 
need changing. 
 
1 
 
0 
 
5 
 B. I have risky drug use behaviors 
that need changing. 
 
1 
 
0 
 
5 
 C. I have risky drinking behaviors 
that need changing. 
 
1 
 
0 
 
5 
      
HIV2. Which of these do you think is most 
risky in terms of causing HIV/AIDS- 
not using condoms, sharing needles, or 
using alcohol or drugs before or during 
sex? 
Not using condoms 1 
Sharing needles 2 
Using alcohol or 
drugs before or 
during sex 
  
 
3 
HIV3. Do you think a steady partner has ever cheated on 
you? 
 
NO 
 
1 
  YES 5 
HIV4. Have you ever cheated on one of your steady 
partners? 
 
NO 
 
1 
  YES 5 
HIV5. Do you feel that having one sex partner is more safe 
than having two or more sex partners? 
NO 1 
 YES 5 
HIV6. I am going to read some statements and I’d like you to tell me if you agree, 
disagree, or are neutral. 
   Agree Neutral Disagree 
A. I am in control of whether or not I get the 
HIV virus. 
   
B. If I get the HIV virus, it is my destiny- 
meaning it is meant to be,  
   
C. Other people play a big part in whether I get 
the HIV virus. 
   
D. Whether or not I get the HIV virus depends 
on my sex partner. 
   
E. My own behaviors determine whether I get 
HIV virus. 
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Appendix B  
Average Number of HIV Tests by Knowledge 
        
       95% CI 
Actions Prior and After Sex to Prevent HIV n M SD t df p LL UL 
Washed genitals before sex with soap?         
Yes 321 3.99 7.29 
-.224 641 .82 -1.18 .94 
No 338 3.87 6.54 
Washed partner’s genitals before sex with soap         
Yes 299 4.24 7.62 
-1.02 576 .31 -1.64 .522 
No 360 3.68 6.27 
Washed your genitals after sex with soap         
Yes 415 3.90 6.69 
.133 475 .89 -1.05 1.20 
No 244 3.98 7.29 
Not let your partner ejaculate in you?         
Yes 262 3.93 7.91 
-.024 656 .98 -1.00 .98 
No 397 3.94 5.05 
Douched after sex?         
Yes 298 4.24 8.15 
1.49 610 .14 -.247 1.79 
No 361 3.51 5.01 
Urinated after sex?         
Yes 334 4.14 7.17 
.756 650 .45 -.651 1.47 
No 325 3.73 6.66 
Washed your genitals after sex with alcohol?         
Yes 88 4.10 7.09 
-.292 132 .77 -1.53 1.14 
No 571 3.91 5.69 
Washed your partner’s genitals after sex with alcohol?         
Yes 79 4.30 5.55 
-.613 116 .54 -1.79 .94 
No 580 3.88 7.08 
Took antibiotics after sex?         
Yes 76 3.86 3.20 
.182 198 .86 -.848 1.02 
No 583 3.94 7.26 
Had sex with only healthy looking people?         
Yes 309 4.04 6.99 
-.362 643 .72 -1.26 .87 
No 350 3.84 6.85 
Washed your genitals with bleach or peroxide after sex?         
Yes  51 6.92 5.78 
-1.58 51 .12 -7.37 .89 
No 608 3.68 5.78 
Washed your partner’s genitals with bleach or peroxide after sex?         
Yes 41 4.44 6.76 
-.501 46 .62 -2.75 1.65 
No 619 3.89 6.92 
Asked your partner if they are HIV positive?         
Yes 393 4.65 8.48 
-3.79 539 .00* -2.71 -.86 
No 266 2.87 3.20 
Substitute oral sex for vaginal sex?         
Yes 101 5.69 11.18 
-1.83 110 .07 -4.38 .18 
No 558 3.61 5.77 
Substituted anal sex for vaginal sex?         
Yes  22 4.09 6.73 
-.113 23 .91 -3.19 2.86 
No 637 3.93 6.92 
Asked your partner for their sex history?         
Yes 276 4.66 8.04 
-2.21 480 .03* -2.38 -.137 
No 383 3.40 5.93 
Have you or your partner used ear wax to determine if you had an 
STD? 
   
     
Yes 33 3.58 3.47 
.698 51 .49 -.889 1.84 
No 569 4.05 7.36 
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Appendix C  
Average Number of HIV Tests by Reported HIV Attitudes 
        
       95% CI 
Attitudes n M SD t df p LL UL 
I have risky sexual behaviors that need 
changing. 
        
Agree 254 3.76 4.16 
-.536 715 .592 -1.11 .64 
Disagree 463 4.00 7.74 
I have risky drug use behaviors that need 
changing. 
        
Agree 355 4.29 8.19 
1.52 560 .128 -.219 1.74 
Disagree 370 3.53 4.71 
I have risky drinking behaviors that need 
changing 
        
Agree 287 4.44 9.27 
1.60 355 .110 -.210 2.07 
Disagree 441 3.51 3.98 
Do you think a steady partner has ever cheated 
on you? 
        
Yes 506 4.13 7.29 
-1.75 688 .08 -1.64 .09 
No 243 3.35 4.67 
Have you ever cheated one  of your steady 
partners 
        
Yes 461 4.25 7.49 
-2.19 747 .03* -1.84 -.10 
No 288 3.28 4.67 
Do you feel having one sex partner is more safe 
than having two or more sex partners 
        
Yes 637 3.89 6.96 
-.266 283 .79 -.978 .75 
No 112 3.78 3.60 
I am in control of whether or not I get the HIV 
virus 
        
Agree 475 4.11 7.66 
1.47 710 .14 -.216 1.51 
Disagree 239 3.46 4.06 
If I get the HIV virus, it is my destiny meaning 
it is meant to be. 
        
Agree 189 3.57 3.65 
-.998 643 .32 -1.23 .40 
Disagree 529 3.98 7.31 
Other people play a big part in whether I get the 
HIV virus 
        
Agree 374 3.76 4.70 
-.635 555 .53 -1.30 .67 
Disagree 354 4.08 8.22 
Whether or not I get HIV virus depends on my 
sex partner 
        
Agree 437 3.75 6.57 
-.541 596 .59 -1.27 .72 
Disagree 285 4.03 6.74 
My own behaviors determine whether I get 
HIV virus 
        
Agree 629 4.06 7.00 
2.50 288 .01* .228 1.92 
Disagree 106 2.98 3.37 
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Appendix D 
Average Number of HIV Tests by Trading Sex and Not Trading Sex 
        
       95% CI 
Traded Sex in Past 4 Months n M SD t df p LL UL 
Alcohol         
Yes 16 5.38 5.58 
-.956 17 .35 
-
4.43 
1.67 
No 116 3.99 4.13 
Marijuana         
Yes 5 4.60 4.10 
-.227 4.37 .83 
-
5.46 
4.61 
No 126 4.17 4.36 
Crack/Cocaine         
Yes 124 4.14 4.33 
.569 6.63 .59 
-
3.22 
5.23 
No 7 5.14 4.56 
Heroin         
Yes 4 2.50 2.38 
1.39 3.67 .24 
-
1.86 
5.35 
No 127 4.24 4.38 
Heroin & Cocaine mix/Speedball         
Yes 131 4.19 4.33 
- - - - - 
No 0 - - 
Amphetamines         
Yes 1 - - 
- - - - - 
No 130 4.22 4.34 
Club Drugs         
Yes 1 - - 
- - - - - 
No 130 4.22 4.34 
Other Drugs         
Yes 2 1.00 1.41 
3.03 1.31 .15 
-
4.65 
11.13 
No 129 4.24 4.35 
Money         
Yes 326 4.84 4.32 
-3.27 452 .001* 
-
2.71 
-.68 
No 422 3.14 4.33 
Food         
Yes 130 5.62 10.08 
-2.32 145 .02* 
-
3.91 
-.31 
No 618 3.51 5.49 
Place to Stay         
Yes  109 6.12 10.52 
-2.54 118 .01* 
-
4.66 
-.58 
No 639 3.50 5.54 
Clothes         
Yes 51 5.02 6.61 
-1.28 57.5 .21 
-
3.14 
.70 
No 697 3.80 6.56 
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Appendix E 
Binary Logistic Regression: Knowledge about Risky Sexual Behavior and Influence 
to HIV Test 
Classification Table
a,b
 
 Observed Predicted 
 Y1N0HIV Percentage 
Correct  No Yes 
Step 0 
Y1N0HIV 
No 0 68 .0 
Yes 0 534 100.0 
Overall Percentage   88.7 
a. Constant is included in the model. 
b. The cut value is .500 
 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 0 Constant 2.061 .129 256.190 1 .000 7.853 
 
 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 
Step 31.327 17 .018 
Block 31.327 17 .018 
Model 31.327 17 .018 
 
Model Summary 
Step -2 Log likelihood Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 393.267
a
 .051 .100 
a. Estimation terminated at iteration number 6 because parameter 
estimates changed by less than .001. 
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Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 
SA50_A -.090 .128 .502 1 .479 .914 .711 1.173 
SA50_B -.213 .119 3.171 1 .075 .808 .640 1.022 
SA50_C .064 .131 .242 1 .623 1.066 .825 1.378 
SA50_D .143 .083 2.993 1 .084 1.154 .981 1.356 
SA50_E -.129 .093 1.924 1 .165 .879 .732 1.055 
SA50_F .168 .097 3.022 1 .082 1.183 .979 1.429 
SA50_G -.192 .142 1.833 1 .176 .825 .625 1.090 
SA50_H .169 .171 .981 1 .322 1.185 .847 1.656 
SA50_I .204 .163 1.561 1 .211 1.226 .891 1.687 
SA50_J -.041 .075 .295 1 .587 .960 .829 1.112 
SA50_K .341 .280 1.484 1 .223 1.406 .813 2.432 
SA50_L -.121 .293 .171 1 .679 .886 .499 1.573 
SA50_M .235 .081 8.490 1 .004 1.265 1.080 1.482 
SA50_N .097 .138 .493 1 .483 1.102 .840 1.446 
SA50_O .077 .287 .073 1 .787 1.081 .616 1.896 
SA50_P -.053 .080 .435 1 .510 .949 .811 1.110 
SA50_Q -.013 .163 .006 1 .938 .987 .717 1.360 
Constant 1.098 .485 5.124 1 .024 2.998   
a. Variable(s) entered on step 1: SA50_A, SA50_B, SA50_C, SA50_D, SA50_E, SA50_F, SA50_G, 
SA50_H, SA50_I, SA50_J, SA50_K, SA50_L, SA50_M, SA50_N, SA50_O, SA50_P, SA50_Q. 
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Appendix F 
Binary Logistic Regression: Attitudes about Risky Sexual Behavior and Influence to 
HIV Test 
Classification Table
a,b
 
 Observed Predicted 
 Y1N0HIV Percentage 
Correct  No Yes 
Step 0 
Y1N0HIV 
No 0 77 .0 
Yes 0 672 100.0 
Overall Percentage   89.7 
a. Constant is included in the model. 
b. The cut value is .500 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 0 Constant 2.166 .120 324.248 1 .000 8.727 
 
Omnibus Tests of Model Coefficients 
 Chi-square df Sig. 
Step 1 
Step 15.610 20 .741 
Block 15.610 20 .741 
Model 15.610 20 .741 
 
Model Summary 
Step -2 Log likelihood Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 480.528
a
 .021 .043 
a. Estimation terminated at iteration number 5 because parameter 
estimates changed by less than .001. 
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Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 
HIV1_A   4.195 2 .123    
HIV1_A(1) .776 .813 .912 1 .340 2.173 .442 10.682 
HIV1_A(2) .609 .319 3.645 1 .056 1.838 .984 3.434 
HIV1_B   4.213 2 .122    
HIV1_B(1) .621 .916 .459 1 .498 1.861 .309 11.214 
HIV1_B(2) .604 .299 4.075 1 .044 1.829 1.018 3.288 
HIV1_C   2.788 2 .248    
HIV1_C(1) -.957 .771 1.542 1 .214 .384 .085 1.739 
HIV1_C(2) -.387 .296 1.704 1 .192 .679 .380 1.214 
HIV2 -.122 .218 .312 1 .576 .885 .578 1.357 
HIV3 -.053 .071 .558 1 .455 .948 .824 1.090 
HIV4 .033 .069 .234 1 .628 1.034 .903 1.184 
HIV5 -.077 .096 .650 1 .420 .926 .767 1.117 
HIV6_A   .507 2 .776    
HIV6_A(1) .060 .601 .010 1 .920 1.062 .327 3.450 
HIV6_A(2) .190 .270 .494 1 .482 1.209 .712 2.051 
HIV6_B   .085 2 .959    
HIV6_B(1) .198 .686 .083 1 .773 1.218 .317 4.678 
HIV6_B(2) -.005 .298 .000 1 .987 .995 .555 1.785 
HIV6_C   .374 2 .830    
HIV6_C(1) -.251 .711 .125 1 .724 .778 .193 3.133 
HIV6_C(2) -.152 .269 .320 1 .571 .859 .506 1.456 
HIV6_D   .174 2 .917    
HIV6_D(1) -.008 .704 .000 1 .991 .992 .250 3.947 
HIV6_D(2) .110 .275 .160 1 .689 1.116 .651 1.915 
HIV6_E   .253 2 .881    
HIV6_E(1) -.165 .883 .035 1 .852 .848 .150 4.782 
HIV6_E(2) .133 .347 .146 1 .702 1.142 .579 2.253 
Constant 2.292 .737 9.673 1 .002 9.897   
a. Variable(s) entered on step 1: HIV1_A, HIV1_B, HIV1_C, HIV2, HIV3, HIV4, HIV5, HIV6_A, HIV6_B, 
HIV6_C, HIV6_D, HIV6_E. 
 
 
 Green, Lisa, UMSL 134 
 
Appendix G 
Binary Logistic Regression: Attitudes and Knowledge about Risky Sexual Behavior 
Influence to HIV Test 
Classification Table
a,b
 
 Observed Predicted 
 HIV test Yes or NO Percentage 
Correct  NO Yes 
Step 0 
HIV test Yes or NO 
NO 0 70 .0 
Yes 0 536 100.0 
Overall Percentage   88.4 
a. Constant is included in the model. 
b. The cut value is .500 
 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Step 0 Constant 2.036 .127 256.562 1 .000 7.657 
 
Model Summary 
Step -2 Log likelihood Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 384.300
a
 .078 .153 
a. Estimation terminated at iteration number 6 because parameter 
estimates changed by less than .001. 
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Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 
SA50_A -.099 .131 .572 1 .450 .906 .700 1.171 
SA50_B -.244 .127 3.679 1 .055 .784 .611 1.005 
SA50_C .107 .140 .587 1 .444 1.113 .846 1.466 
SA50_D .136 .085 2.586 1 .108 1.146 .971 1.353 
SA50_E -.139 .095 2.151 1 .142 .870 .723 1.048 
SA50_F .143 .101 2.034 1 .154 1.154 .948 1.405 
SA50_G -.247 .151 2.677 1 .102 .781 .581 1.050 
SA50_H .195 .184 1.126 1 .289 1.215 .848 1.741 
SA50_I .212 .168 1.594 1 .207 1.236 .889 1.718 
SA50_J -.049 .077 .415 1 .519 .952 .819 1.106 
SA50_K .325 .304 1.147 1 .284 1.384 .763 2.510 
SA50_L -.065 .317 .042 1 .838 .937 .504 1.744 
SA50_M .265 .081 10.582 1 .001 1.303 1.111 1.529 
SA50_N .041 .145 .082 1 .775 1.042 .785 1.384 
SA50_O .086 .292 .087 1 .768 1.090 .615 1.932 
SA50_P -.042 .082 .262 1 .609 .959 .816 1.127 
SA50_Q -.054 .172 .098 1 .754 .948 .677 1.327 
HIV1_A   4.428 2 .109    
HIV1_A(1) .947 1.193 .630 1 .428 2.577 .249 26.709 
HIV1_A(2) .727 .359 4.102 1 .043 2.068 1.024 4.177 
HIV1_B   4.166 2 .125    
HIV1_B(1) 1.452 1.441 1.016 1 .314 4.273 .254 72.012 
HIV1_B(2) .648 .336 3.728 1 .053 1.912 .990 3.693 
HIV1_C   1.959 2 .376    
HIV1_C(1) -.948 1.405 .455 1 .500 .388 .025 6.081 
HIV1_C(2) -.432 .327 1.751 1 .186 .649 .342 1.231 
HIV2 -.173 .246 .492 1 .483 .841 .519 1.364 
HIV3 -.096 .081 1.417 1 .234 .908 .775 1.064 
HIV4 .025 .077 .109 1 .742 1.026 .882 1.193 
HIV5 -.028 .103 .076 1 .782 .972 .794 1.189 
HIV6_A   .765 2 .682    
HIV6_A(1) .465 .702 .440 1 .507 1.592 .403 6.300 
HIV6_A(2) .225 .309 .532 1 .466 1.253 .684 2.294 
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HIV6_B   .706 2 .702    
HIV6_B(1) .669 .901 .551 1 .458 1.952 .334 11.418 
HIV6_B(2) -.110 .328 .112 1 .738 .896 .471 1.705 
HIV6_C   .880 2 .644    
HIV6_C(1) -.407 .843 .233 1 .629 .666 .128 3.472 
HIV6_C(2) -.267 .298 .803 1 .370 .765 .426 1.374 
HIV6_D   .514 2 .773    
HIV6_D(1) -.029 .772 .001 1 .970 .972 .214 4.411 
HIV6_D(2) .214 .315 .460 1 .498 1.239 .667 2.299 
HIV6_E   .850 2 .654    
HIV6_E(1) -.758 1.013 .560 1 .454 .469 .064 3.415 
HIV6_E(2) .120 .374 .103 1 .749 1.127 .542 2.345 
Constant 1.295 .895 2.094 1 .148 3.650   
a. Variable(s) entered on step 1: SA50_A, SA50_B, SA50_C, SA50_D, SA50_E, SA50_F, SA50_G, 
SA50_H, SA50_I, SA50_J, SA50_K, SA50_L, SA50_M, SA50_N, SA50_O, SA50_P, SA50_Q, HIV1_A, 
HIV1_B, HIV1_C, HIV2, HIV3, HIV4, HIV5, HIV6_A, HIV6_B, HIV6_C, HIV6_D, HIV6_E. 
 
 
 
 
 
 
 
 
 
 
 
 
 
